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Nayin Daepal Pathirana
CHENISny AND BIOLOGICAL ACTIVITY OF IRON QUINONEOXIHIC COMPLEXES
ABSTBACT
The synthesis and structure of 1,2-quinone mono-oximes 
have been reviewed. The reaction of 3-hydroxyphenol,
3-hydroxy-2-aethylphenol, 3-hydroxy-5-methylphenol and 
N-acetyl-3-aainophenol with amyl nitrite/M(OEt) (M - Na 
or K) has been systematically examined. It has been 
found that the complex formed depends on the reaction 
temperature and phenol/M(OEt) ratio. Infra-red 
spectroscopic studies have shown that in the solid state 
5-hydroxy-l,2-benzoquinone 2-oxime (hqoH,),
5-hydroxy-3-methyl-l,2-benzoquinone 2-oxime (3-MehqoH2), 
5-hydroxy-6-methyl-l,2-benzoquinone 2-oxime (e-MehqoH,) 
and H-acetyl-5-amino- 1,2-benzoquinone 2-oxime (N-AcqoH) 
and their sodium and potassium complexes exist in the 
oximic form rather than the nitroso form. Nuclear 
magnetic resonance studies have also shown that in 
d,-DHSO solution hqoH,, 3-MehqoH, and 6-MehqoH} and 
their sodium complexes exist in one form only which is 
oximic in character. However, in DjO the results for the 
sodium complexes of hqoH, and e-MeqoH, indicate the 
presence of at least two species. In the case of the 
sodium 5-hydroxy-6-methyl-l,2-benzoquinone 2-oximate 
these species are oximic in character. An X-ray 
crystallographic study of e-HehqoH, has shown that in 
the solid state this compound exists in the 1,4- rather 
than the 1,2-quinone 2-oxlmic form.
The synthesis of iron(II) complexes of hqoH,, 3-MehqoH] 
and 6-HehqoH] using the direct and the nitrosation 
methods was examined. The direct method gave rise to the 
complexes Fe(hqoH), OHjO, Fe(3-HehqoH), and
Fe(6-NehqoH)2 '2H20 whereas the nitrosation method gave 
rise to ill-defined solids. Na[Fe(N-Acqo), ]-4H20 was 
obtained by nitrosation of N-acetyl-3-aminopnenol in the 
presence of Iron(II) ammonium sulphate. Hossbauer and 
magnetic studies indicate that Na[Fe(N-Acqo)j]-4H20 is a 
low spin iron(II) complex whereas the bischelates have 
properties indicative of the S - 1 spin state.
In-vlvo assesment of the iron chelating ability of 
hqoHj, 3-MehqoH2, 6-MehqoH2, N-AcqoH , N,N-dimethyl-5- 
amino-1,2-benzoquinone 2-oxime and vloluric acid was 
carried out using a normal rat model. The chelators hqoH, 
and 6-HehqoH2were found to be effective in removing iron 
when administered intra-muscularly but they also caused 
the excretion of magnesium. Their activity was lower 
than that of desferrioxamine and neither was effective 
when administered orally.
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SYNTHESIS AND PSOPESTICS OP a-HYDEOZY-l,2-BENZOQUINONE 
MONO-OXIHES, N-ACETYL-5-ANINO-l,2-BENZOQUINOHE 2-OZIME 
AND SONE or THEIK GEOVP 1 AND GROUP II METAL COMPLEXES
1.1 Introduction
Ring nitrosation of aromatic compounds is difficult 
unless activating groups are attached to the aromatic 
ring, e.g. hydroxy or amino. The hydroxy group is 
ortho/para directing and theoretically nitrosation of 
phenols can yield a mixture of 2- and 4-isomers. In 
practice for most phenols the predominant product of 
nitrosation with sodium nitrite/acid is the 4-isomer 
(Reaction 1.1) and the 2-isomer is only formed in a few 
cases, e.g. N,N-dimethyl-3-aminophenol 
(Reaction 1.2).** In marked contrast nitrosation in the 
2—position occurs readily in the presence of a 
transition metal salt (Reaction 1.3) .*•* In this case 
the 2-nltrosophenol is obtained in the form of its metal 
complex. Significantly, using this approach nitrosation 
in the 2-position has been accomplished even in the case 
of phenols which do not afford the 2-nitrosated product 
on treatment with sodium nitrlte/acid.
NaNO./Acid
Raactlon l.l
NaNOa/Acid
'N(CH,),
Reaction 1.2
,OH
M"*/NaNOj/Acid M
Reaction 1.3
4-Nitrosophenol has been isolated in two fo»s.‘ One of 
these forms has been assigned a nitrosophenolic 
structure (Fig. 1.1a) and the other a quinone oxinic 
structure (Fig. l.lb). A tautomeric equilibrium between 
these two forms has been suggested to exist in solution. 
Two forms, yellow crystals and white fibers, have also 
been isolated in the case of 2-chloro-
5-M«thyl-4-nitro>ophenol. An X-Ray cryatallographlc 
study of tha yellow crystals has revealed It has qulnone 
oxislc structure with the OH of the NOH group syn to the 
chlorine (Fig. 1 . 2 a ) F r o s  chesical evidence and the 
Icnowledge of the structure of the syn fora, an anti 
quinone oxiaic structure (Fig. 1.2b) has been suggested 
for the white fillers.* This agrees with the observed 
powder diagraas of the white fibers.* Siailar proposals 
have been aade for 5-broao-5-aethyl-l,4-benzoquinone
4-oxiae which has also been Isolated in a yellow 
crystalline fora and as white fibers.*
Fig. 1.1
I I
CHi
H 0 <
Fig. 1.2
As in ths cass of 4-nltrosophenol sosa 2-nitrosophenols 
havs also bssn isolated in two forms. Initially these 
were assigned nitrosophenolic (Fig 1.3a) and qulnone 
oximic structures (Fig. 1.3b) and considered to be 
tautomeric in solution. However, X-ray crystallographic 
studies have demonstrated that in the solid state both 
forms are qulnone oximic in character and that the 
Isolation of two forms relates to the possibility of the 
oxlmic species existing in a syn or anti configuration 
(Fig. 1.4). For example, 5-methoxy-2-nltrosophenol was 
found to crystalise as green rectangular plates from 
t>enzene and as red needles from ethanol.’ Initially, the 
qulnone oximic structure was assigned to the red form 
(a-form) and the nitrosophenolic structure to the green 
form 03-form). An X-ray crystallographic study of the 
a-form showed it to have quinone oximic structure with 
the OH of the NOH group anti to the CO g r o u p . I n  the 
case of the 5-propoxy-2-nitrosophenol which also exists 
in a- and fS-forms, X-ray studies showed the latter to be 
qulnone oximic rather than nitrosophenolic.“ However, 
in this case the compound has the OH of the NOH group 
syn to the CO group. The significance of the oximic 
structure has also been demonstrated by the finding that 
all 2-nitrosophenols characterised by X-ray 
crystallography have quinone oximic structures in the 
solid state (see Chapter 2).
Fig 1.3
>NOH
a - %
syn
Fig. 1.4
In solution, i.r., u.v. and n.m.r. studies have 
Indicated the presence of an equllibrlun between quinone 
oxinic and nitrosophenolic species, (also see
Section 1.5).’*'**
In view of the above the 2-nitrosophenol/l,2-qulnone 
nono-oxine systen nay be represented as shown in 
Schene 1.1. Because of the important contribution from 
the oximic forms, in this thesis the compounds will, 
hereafter be referred to as quinone mono-oximes.
'VOH
Schene 1.1
In the case of 5-hydroxy-l,2-benzoquinone sono-oxiines 
additional contribution fro* the 1,4-quinone 4-oxime 
isomers is also a possibility (Scheme 1.2)* An X-ray 
crystallographic investigation carried out during the 
present study has shown that the product arising from 
the nitrosation of 3-hydroxy-2-methylphenol exists in 
the 1,4-quinone 4-oxime form ((a) in Scheme 1.2) rather 
than in the 1,2-quinone 2-oxime form ((b) in 
Schene 1.2). However, for the sa)ce of convenience 
quinone mono-oximes derived from 3-hydroxyphenols will 
be referred to as 5-hydroxy-l,2-benzoquinone mono-oximes 
in this thesis.
Schene 1.2
X, 2 Synthesla of 1,2-Quinone Mono-oxlae»
A variety of direct and indirect nethods for the 
synthesis of 1,2-guinone Bono-oxines have been reported. 
In the direct methods the X,2-quinone aono-oxiae itself 
is obtainable from the reaction. In the case of the 
indirect methods a metal complex of the 1,2-qulnone 
mono-oxime is first formed from which the free oxime may 
be isolated. The isolation of the free oxime is 
achievable by acidification of the complex or by passing 
a solution of the complex over an ion exchange resin. In 
the case of selected Lewis base adducts of copper(II)
1,2-qulnone mono-oximato complexes the isolation of the 
frme oxime has also been achieved by treating their 
methanollc solutions with silica.
Direct Hethode
Nltroeatlon s£ Phenols using sodiue nitrlte/acid 
This eethod involves the reaction of a phenol, an acid 
(usually acetic acid) and sodium nitrite. Several
1,2-qpiinone mono-oximes derived from 3-substltuted 
phenols (e.g. Reaction 1.2) have been obtained by this 
method but in some cases the 4-isomer is also formed.'’^ 
Nitrosation of other phenols does not lead to the
2-isomer even when the 4-positlon is substituted. The 
reasons for this have not been established but 
Instability of the 2-substltuted product towards acids 
may be a cause.
Reaction hvdroxvlamine hydrochloride with a ouinone 
A very limited number of 1,2-quinone mono-oximes have 
been synthesized by heating hydroxylamine hydrochloride 
with the corresponding quinone (Reaction 1.4).’^
NH,OHHCI
40H
Reaction 1.4
Photochemical synthesis
Two methods for the photochemical synthesis of
1,2-quinone mono-oximes have been described. The first

Th« quinoM aono-oxiM of 1,10>phenanthroline has baen 
by tha acidification of its sodiun coaplax 
which is obtainable by the alkali induced rearrangeaent 
of 5-nitro-l,lo-phenanthroline (Reaction 1.7).“
/NO, .NONa
NaOH
90-100 ®C
Reaction 1.7
In the case of alkali aetal complexes of
3-hydroxy-l,2-banzoquinone nono-oximes, which are 
obtainable by the action of sodium alkoxide and alkyl 
nitrite on a 3-hydroxyphanol (Reaction 1.8),^' 
acidification affords the free ligand but in the 1,4- 
tautomerlc form (see Chapter 2).
Amyl Nitrite
CHjCHjONa TT^'^^:/^N0Na
Reaction 1.8
Recent studies have shown that potassium or sodiun 
complexes of 1,2-naphthoquinone 1-oxine (l-nqoH) and
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1,2-naphthoqulnone 2-oxlae (2-nqoH) can be obtained by
reactlnq their conplexea, M(l-nqo)^, M(2-nqo)^ (M Cu
or Mi*'*) Cu(2-nqo)^.dipy or Cu(2-nqo) (Ph^ P)^ with 
potasaiua or aodixui cyanide.^ This route to potassium 
and sodium complexes has a potentially wide range of 
applicability.
The preparation of 1,2-quinone mono-oximes by the 
acidification of their transition metal complexes has 
also been reported by several workers.
Generally these reports lack experimental details. In 
this procedure the metal complex is treated with an 
aqueous acid and the resultant oxime is extracted with 
an organic solvent. Solutions of several 1,2-quinone 
mono-oximes have been prepared but isolation of the 
oxime from the solution has only been accomplished in 
very few cases.
USfi a£ iso  exchange £fisiOB
This approach which is essentially a modification of the 
above method has been used to obtain 1,2-quinone 
mono-oximes in high yield and purity from their metal 
complexes.^ The technique has proved applicable to the 
preparation of N-acetyl-5-amino-l,2-benzoquinone 2-oxime 
(N-AcqoH) from its nickel complex. Significantly, this 
oxime cannot be prepared by acidification of its metal 
complexes or by the direct nltrosatlon of 
N-acetyl-3-aminophenol (see later).
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Reaction si Cuiaol^X - dlpy sr phenl adducts so 
allica
Recently a Halted number of 1,2-qulnone aono-oxlmes 
have been prepared by stirring methanolIc solutions of 
bis(1,2-qulnone mono-oxlmato)copper(II) adducts of 
1,10-phenanthrollne or 2,2'-dlpyrldyl with silica. The 
liberated ligand Is Isolated by removing the methanol 
from the reaction mixture and extracting the residue 
with an organic solvent (Reaction 1.9).^
Cu(qo)^-X Silica
Methanol
Cu(qo)-X qoH
Reaction 1.9
1.3 Behaviour of 3-Hydroxyphenols and M-Acetyl-
3-amlnophenol Towards Hltrosatlon
The nitrosation of 3-hydroxyphenols has been
Investigated by several workers.**’^ *’^*’”  These
compounds can undergo mono- and/or dl-nltrosatlon, 
depending on the nature and position of the substituents 
and the method of nitrosation employed. 
3-Hydroxyphenol Itself can )»e dlnltrosated by amyl 
nltrlte/sodlum ethoxlde at room temperature as well as 
by sodium nltrlte/acetlc acid (Reaction 1.10). 
Nono-nltrosatlon can be achieved by using amyl
nltrlte/sodlum ethoxlde at -10 *C.“  In the case of 
2-methyl-3-hydroxyphenol the mono-nltrosated product is
13
forMd irrespectiv« of the aethod of nitroeation.“  The 
nature of the alkali natal conplexes arising fron the 
reactions involving amyl nitrite (Reaction 1.8) has not 
been systematically Investigated. Such a complex may be 
mono-metallic or dl-metallic.
"XT NaNOaAcid
NOH
'NOH
Reaction 1.10
In this study the behaviour of 3-hydroxyphenol, of its 
homologues 3-hydroxy-2-methylphenol and 
3-hydroxy-5-methylphenol, and of the related compound 
i*~acetyl-3-aminophenol towards nitrosation by sodium 
nitrite/acid and amyl nitrite/base has been studied in 
greater detail.
The studies have confirmed previous results of 
nitrosation reactions Involving sodium nitrite/acid 
(Table 1.1).
In the case of reactions Involving amyl nitrlte/base, it 
can be concluded that the nature of the product is 
primarily dependent on the reaction temperature and the 
molar ratio of the reactants. The nature of the base 
used i.e. sodium hydroxide or sodium ethoxlde, has no
14

•ffact on tho natur* of tha product but affects the 
yield.
In the case of the 3-hydroxyphenol it has now been 
established that, contrary to a previous report,“  the 
reaction involving sodium hydroxide and amyl nitrite at 
-10 *C affords a mixture of the mono- and di-sodium 
derivatives of the mono-nitrosated phenol when a 1:1.4 
phenol to sodiim hydroxide ratio is used. The 
mono-sodium derivative is obtained using a 1:1 phenol to 
sodium hydroxide ratio whereas the disodium by using a 
1:2 ratio. Analogous behaviour is shown by 
3-hydroxy-2-methylphenol and 3-hydroxy-5-methylphenol.
When the reaction of the 3-hydroxyphenols with amyl 
nitrite/sodium ethoxide involving 1:1 phenol to sodium 
ethoxide ratio is carried out at room temperature 
3-hydroxyphenol and 3-hydroxy-5-methylphenol afford the 
mono-sodium derivative of the dinltrosated phenol. In 
contrast, the analogous reaction of 
3-hydroxy-2-methylphenol affords the mono-sodium 
derivative of the nono-nitrosated phenol.
**~*®*tyl-3-aminophenol afforded a mixture of products on 
treatment with sodium nitrite/acid or amyl 
nitrite/sodium ethoxide. However, neither of the 
mixtures had the ability to chelate iron(II) suggesting 
that N-acetyl-5-amino-1,2-benzoguinone 2-oxime is not a
16
product of thM* reactions. This oxislc ligand was 
successfully Isolated from Its nickel cosplex 
[Mi(N-Acqo)j]-«HjO by using the ion exchange method (see 
Section 1.2). The sodium complex of the ligand was 
synthesized by reacting it with sodium ethoxide.
Acidification with acetic acid at 0 *C of the alkali 
metal complexes of the oximes synthesized during this 
study and listed below afforded the respective ligand. 
Hydrochloric acid (4 H) could also be used, however this 
gave lower yields.
Acid 6-MehqoH^H^O
Acid 3-MehqoH^H^O
Acid hqoH
17

Th« foraulations and the t.g.a. rasulta for the free 
ligands as well as the sodium, potassium and calcium 
complexes are presented in Table 1.2.
1.4 Croup 1 and Croup II Metal Compounds of 1.2-Quinone 
Mono-oximes
Previously, very few studies on Group I metal compounds 
of 1,2-quinone mono-oximes have been carried
out. ■ Almost all the studies have involved either
1,2-naphthoquinone 1-oxime or 1,2-naphthoquinone
2-oxime. In the case of Group II metals only one 
complex, Ca(4-Neqo)^, has been reported.“  From
Table 1.3, which summarises all the previous studies, it 
can be seen that there are three main types of Group I 
metal compounds of 1,2-quinone mono-oximes;
(i) Compounds of type M(qo)B_^ (n = 0, 1, 2), which 
contain anionic quinone oximato and neutral 
ligands (e.g. B > H^O).
(ii) Compounds of type M(qo) (qoH) (B)^ (n = 0, 1;
B “ e.g. H^ O) which contain an anionic quinone 
oximato ligand as well as a neutral quinone 
oxlmic ligand.
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(iii) Co«pounds of typ« M(L)(qoH) which contain a 
nautral quinona oxiaic ligand together with a 
anionic ligand L such as the anion of 
2-nitrophenol.
During the present study 11 sodium and potassium 
complexes of the oximes e-HehqoH^, 3-MehqoH^, hqoH^ and 
N-AcqoH were prep>ared. Each of the complexes, except 
Na(N-Acqo), was prepared by the direct reaction of the 
ligand with metal ethoxlde and by the nitrosation of the 
respective phenol with amyl nitrite/netal ethoxide. Only 
the former method was used for the synthesis of 
Na(N-Acqo). In all cases the products were of the type 
M(qo) or M(qo)(B)_^ (where B = H^ O, n - 0  or 1). All 
attempts to synthesize complexes of the type M(qo)(qoH) 
failed. Thus for example when the complexes Na(3-MehqoH) 
and Na(6-HehqoH) were stirred with the corresponding 
free ligand in methanol no adduct formation occurred and 
the starting materials were recovered quantitatively.
The calcium complexes of 3-MehqoH^ and 6-MehqoH^ were 
prepared by stirring an excess of the ligand in 
methanol-water (4:1) with calcium hydroxide. The excess 
ligand was removed by washing the crude product with 
diethyl ether. Elemental analysis indicate that in both 
cases the anhydrous complex is formed. In the case of 
hqoH^, the reaction led to the decomposition of the 
ligand and hence no calcium complex was obtained.
20
Tabl* 1.3 AlKall Metal CoBPlexe» fi£ 
Mono-oxlBes
1.2-QulnQne
1,2-qoH CoMplex Data Reported Ref.
1-nqoH Li( 1-nqo) el •1 A, 30
Li(l-nqo)(1-nqoH)-B X-ray, el.. A 31
Li{ 1-nqo)(1-nqoH) el., A 31
Na ( 1-nqo) el., B.p., A 30
Na(1-nqo)(phen) el., t.t. 32
Na(l-nqoH)(hbza) el., t.t.. A 33
Na(l-nqoH)(nph) el., t.t.. A 33
K(1-nqo) el., B.p. , A 30
K( 1-nqo)(1-nqoH) el., t.t.. A 30
K(1-nqo)(phen) el., t.t. 32
K(1-nqo)(iapH) el., t.t.. A 33
K(1-nqo)(hquH) el., t.t.. A 33
K(l-nqoH)(nph) el., t.t.. A 33
K(l-nqoH)(hbza) el., t.t.. A 33
Rb(1-nqo) el., B.p., A 30
Rb(1-nqo)(1-nqoH) el., t.t.. A 30
Rb(1-nqo)(iapH) el., t.t.. A 33
Rb(l-nqo)(hquH) el., t.t.. A 33
Rb(l-nqoH)(hbza) el., t.t.. A 33
Rb(l-nqoH)(nph) el., t.t.. A 33
Ca(1-nqo) el., B.p., A 30
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Table 1.3 Continued
1,2-qoH Coaplex Data Reported Ref.
l-nqoH Ce(l-nqo)(1-nqoH) el., t.t., A 30
Ce(l-nqo)(iapH) el., t.t., A 33
Cs(l-nqoH)(hbza) el.. t.t., A 33
Cs(l-nqoH)(nph) el., t.t., A 33
2-nqoH Li(2-nqo)(2-nqoH) el., t.t. 34
Na(2-nqo)(2-nqoH) el., t.t. 34
K(2-nqo)(2-nqoH) el., t.t. 34
Rb(2-nqo)(2-nqoH) el., t.t. 34
Cs(2-nqo)(2-nqoH) el.. t.t. 34
Cs(2-nqo)(2-nqoH)^ el., t.t. 34
phenqoH Na(phenqo)■2H^O el. 20
4-ClqoH K(4-Clqo) X-ray 35
hqoH^ (hqo) el. 26
4-MeqoH Ca(4-Meqo)^ - 36
l-n q »K «l, 2-HAphthoq«lneo« 1-oxIm ; 2-nqoK«l» 2*’Naphtho-
qulnoM 2->«xlMi ^C ihanol; ph*QPl»10-Fh«Mnthrolln«;
hb«a^2«-lhrdre*yb*«elc *etd ; nphl^2-Mltroph«nol;
lap*eIsenltreeo#ceteplwKwne; hqidlM-MydroKyqulnol Ine;
•  l.«C l«aM ktxl M M ljrsl«; A«€»nductSTltjri
point; t .t .«T r «n o lt lo n  tMporoturo <aftor
tM porotoro • oo lld  r«M ln s  which M lto  ot 
tonporoiuro m  « . »  o m  ltof.34).
B .p .«N «U lng
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1,5 yropTtl«« MKI Striictaral Studla» of hqoH^. 
a-MohqoHj. <-Mo1kioH^ . W-AcqoH an«l Thwlr Sodlua,
Potaaaluw and Calcliaa Coaplaaaa
1.5.1 gtnwaX Praptrtidp
The quinone aono-oxines synthesized during this study 
were coloured solids which decoaposed on heating between 
130 - 140 *C. Generally, they were appreciably soluble 
in organic solvents (e.g. ethanol) and also showed some 
solubility in water.
All the sodiua, potassium and calclua complexes of the 
oxiaes were coloured coapounds which had limited 
solubility in ethyl acetate but were very soluble in 
awthanol and water. Generally, the al)call metal 
complexes decomposed on heating at a temperature 
ca. 75 *C higher than that of the respective ligands, 
(Table 1.2). The calcium complexes showed even greater 
theraal stability, e.g. Ca(6-MehqoH)^ decoaposed at 
280 *C whereas the decomposition temperature of 
8-HehqoH^ was 135 *C.
1.5.2 Infra-red SMCtra
As noted earlier 3-hydroxy-l,2-quinone aono-oxiaes can 
exhibit a number of isomeric and tautomeric structures. 
Scheme 1.2 which demonstrates this is presented again
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h«r* for th« convonienc* of the reader. An X-ray 
crystallographic structure detersination of the
■ono-oxise derived from 2-»ethyl-3-hydroxyphenol (see 
Chapter 2) has shorn that in the solid state the 
cospound has the 1,4- structure, l.e. it exists as 
3-hydroxy-2-sethyl-l,4-benzoquinone 4-oxise ((a) in 
Schese 1.2).
t
■ iCO - x o
Schene 1.2
The i.r. spectruB of four quinone Bono-oxises and nine 
coBplexes have been recorded and all show a strong band 
between 1615 - 1660 cb‘‘ (Table 1.4). In accord with the 
crystallographically established structure, 6-MehqoH^ 
shows a band at 1647 cb*‘ assignable to vCO. This is in 
the region (ca. 1618 - 1668 cb"*) previously reported 
for the vCO absorption of quinone aono-oxiaes.** The 
other ligands investigated during this study, 
i.e. 3-MehqoH^, hqoH^ and N-AcqoH also show siailar vCO
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bands in this rsgion. Thus it can bs concludsd that they 
too sxist in ths quinons oxisic form in the solid state.
Table 1.4 Xhs vSQ Band Assionsents ls£ 
3-Hvdroxv-l■4-benzoQuinone Mono-oxises and sose of their 
Hetal Complexes
Compound wCO /cm’’
6-NehqoH2-H20 1647
Na(6-MehqoH)-H^O 1620
K(6-HehqoH)-H^O 1622
Ca(6-Mehqo)^ 1618
3-MehqoH^HjO 1642
Na(3-MehqoH)-2H^0 1632
K(3-MehqoH) 1645
Ca(3-Mehqo)j 1633
hqoH^ 1638
Na(hqoH) H^O 1625
K(hqoH) 1626
N-AcqoH 1649
Na(H-Acqo) 1638
A strong band in the 1615 - 1660 cm*' region assignable 
to I'CO is also shown by all complexes of 6-MehqoH2,
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3-N*hqoH^ and hqoH^ atudiad (Tabla 1.4). In all cases, 
except K(3-MehqoH), this band appears at a lower 
frequency relative to the vCO band of the respective 
ligand.
The shift to lower frequency observed in the aajority of 
the complexes suggests that the CO group is involved in 
the bonding to the metal. Possible structures involving 
bonding of the CO group are shown in Figs. 1.5 - 1.7. In 
these structures the ligand may be chelating or bridging 
and may have 1,2- or 1,4-quinone character. X-Ray 
crystallographically established examples of structures 
depicted in Pig. 1.5 and Fig. 1.6 have been reported 
Previously. For example in the compound shown in 
Pig. 1.8 the sodium ion is chelated.^ In contrast, in 
the case of potassium 4-chloro-l,2-benzoquinone 
2-oximate, the ligand has 1,2-quinone character and 
bridges two potassium ions (Fig. 1.9).“
In the case of K(3-MehqoH), where the vCO absorption 
occurs at a higher frequency than in the free ligand, 
the qulnone CO is not involved in bonding. Examples of 
complexes in which the CO group is not bonded to the 
metal are )cnown, e.g. the UO^ ** complex derived from 
nqoH shown in (Fig. 1.10).”
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Fig. 1.6
The calcium complexes of 6-HehqoH^ and 3-MehqoH^ are 
most likely to be bis-chelates, in which case the 
observed lowering of the vCO band suggests 1,2-quinone 
character for the ligands (Fig. 1.11). Polymeric 
structures involving ligands with 1,2- or 1,4-quinone 
character are also possible but are not compatible with
27
Fig. 1.8
Pig. 1.9
Fig. 1.10
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th* ralativaly high solubility of tha coaplsx in 
■sthanol.
R'
-  0
R*
i
r ' R'
:H. R*= CHj or
:H. R' sCHj
Fig. 1.11
Ia.2.1 Investigation al Quinone Mono-oximes and their 
Metal ggaplexea by Nuclear Magnetic Resonance 
Spectroscopy
The possibility of nitroso - oxiaino tautomerism in 
quinone mono-oximes has been investigated using n.m.r. 
techniques by several workers.**’“ ’*^ ’” ’ The compounds 
investigated as well as their suggested structures in 
solution are shown in Table 1.5. All compounds 
investigated, except 1,4-benzoquinone 4-oxime and
1,2-naphthoquinone 2-oxime, exist in the oxime form 
irrespective of the solvent. 1,4-Benzoquinone 4-oxime is 
phenolic in m s o  and oximic in chloroform, whereas in 
dioxan and diethyl ether both forms coexist.”  In the 
case of 1,2-naphthoquinone 2-oxlme, a mixture of the two 
forms was found in OHSO/acetlc acid (5%), but only the
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oxiM form was found in ssvsral othsr solvents 
investigated. '*
In this study hqoH^, l-MehqoH^, 6-MehqoH^, N-AcqoH and 
SOTO of their metal complexes were investigated by 
n.m.r. spectroscopy. The complexes were studied both in 
d^-dimethylsulphoxide (d^-DNSO) and deuterixim oxide 
(DO). The free ligands were only studied in d^-mso 
because of their poor solubility in water.
The 'h n.m.r.spectra (Table 1.6) obtained for hqoH^ and
6-MehqoH^ agree with those reported previously.^ 
Evidence that the compounds exist as qulnone mono-oximes 
comes from the fact that two hydroxyl protons are 
observed. If the compounds have a nltroso phenol 
structure then both the acidic protons would be very 
similar and hence have similar chemical shifts. However, 
for these compounds two acidic protons are observed at 
ca. 10.S ppm and ca. 13.5 ppm (Table 1.6), suggesting 
the presence of two different OH groups and hence of an 
oximlc structure. In the case of 1,4-naphthoquinone
4-oxlme, the hydrogen of the oxime group has been 
observed at 13.45 ppm.” By analogy the peak at 
ca. 13.5 ppm observed in the spectra of hqoH^ and 
6-MehqoH^ is assigned to the oximic hydrogen and the 
peak observed at ca. 10.5 ppm is assigned to the 
phenolic hydrogen. Further evidence for the quinone 
oximic structure is provided by consideration of the
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values of ortho coupling constants (J ). Aromatic 
carbon-carbon bonds have less double bond character than 
carbon-carbon double bonds in quinone type compounds, 
and hence are longer. As a result the ortho coupling 
constant is less for a benzenold system 
(e.g. Fig. 1.12a) than for a quinonold system
(e.g. Fig. 1.12b).* Typically, the value for J
for a benzenoid system is ca. 8 Hz., whereas for a 
guinonoid system it is ca. 10 Hz. The coupling constants 
observed for 6-MehqoH^ and hqoH^ are ca. 9.9 Hz 
suggesting that in these compounds the bonds are of 
guinonoid character.
Br
J - 8.0 Hz
H,R' \ h- - 10-5 HZ
Fig. 1.12
3-MehgoH^ shows a single broad peak between 9-15 ppm. 
The broadness of this peak most probably arise because 
of the coalescence of the two OH peaks as a result of 
the rate of exchange of these protons. Therefore a 
qulnonoid structure is also suggested for this compound.
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Tabla 1.6 ‘u Nuclear Magnetic Reeonance Spectral 
Asslgn»ents £ar haoH^. 6-MehaoH^ and 3-MehaoH^
Compound Assignment Multiplicity
(J/Hz)
6/ppm
s 1 (broad) s 13.55
y
HOv ;0 2 d (Jj 3 - 9.9) 7.42
L I 3 (J..3 ‘ ^3.S> 6.19
3H'' ^NOH 4 (broad) s 10.98A2 5 d (J3^  - 2.2) 5.69
5 1 (broad) 8 13.43CH,
T 2 d (J, , - 9.9) 7.45
HO> >o '2,3 '
L I 3 d (Jj 3 = 9.9) 6.273H"V ^Nofi 4 (broad) s 9.96A2 5 s 1.78
5 1,4 (V. broad) s 9-14H
1 2 d (J - 1.3) 2.33HO> i^ O '2,3 '
I I 3 m 6.40
JH'V 5^T40H 5 d (J3^  - 2.4) 5.81CHj
dsOo«Al»t; dd^Doubl«! doubl«ts; sttSlngl«t;
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N.a.r. Soactra fiX Na(haoH). Waf3-W<hflOH) and 
Maf6-MahaoH) in CHSfi
The *H n.a.r. spectra obtained for Na(hqoH), 
Na(6-MehqoH) and Na(3-MehqoH) in d^-DMSO are shown in 
Figs. 1.13 - 1.15 together with suggested assignments. 
The ” c n.m.r. data for the above compounds are given in 
Table 1.7. In all cases the spectra show that only a 
single species exists in d^-DHSO. Although the compounds 
are presented as having 1,2-qulnonoid structures both in 
Figs. 1.13 - 1.15 and Table 1.7, it should be stressed 
that the n.m.r. data are also compatible with
1,4-qulnonold structures. As in the case of the i.r. 
results, the n.m.r. data do not allow the distinction 
between 1,2- and 1,4-qulnonold character.
The values of ortho coupling constants observed for the 
spectra of Na(hqoH) and Na(6-MehqoH) in d^-DMSO (see 
Fig. 1.13- 1.14) suggest that these compounds exist in 
the qulnonold form. Further evidence for this is 
obtained from the ‘^ C n.m.r. spectra which are presented 
in Table 1.7 together with proposed assignments. For 
these compounds as well as for Na(3-MehqoH), n.m.r. 
data indicate the presence of a qulnonoid (>C=*0) and an 
oximlc (>C-N) carbon (Fig. 1.16). The peaks for 
qulnonold and oximlc carbons were assigned by comparison 
with chemical shift data observed for similar compounds. 
Hence, the peak at ca. 183 ppm was assigned to the 
quinonold carbon in comparison with 9,10-anthroquinone*^
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in which th* quinonoid carbons are observed at 183 ppm. 
The peak observed at ca. 167 ppm was assigned to the 
oximic carbon in comparison with ketoximes in which the 
oximic carbon is observed in the range 
ca. 155 - 170 ppm, e.g. in 4,4-dimethylpentan-3-one 
oxime the oxime carbon is observed at 168.1 ppm.*^
In the 'h n.m.r. spectra of all compounds, a noteworthy 
feature is a singlet at ca. 20 ppm due to the hydrogen 
of the OH group. Such a high value is unusual and 
indicates very strong hydrogen bonding.
Quinonoid Carbon
Oximic Carbon
Fig. 1.16
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Table 1.7 £ Nuclear Magnetic Resonance Spectral
A»aiqnagnt» iSL Ha(haoH>. Naf6-MehgoH> and Naf3-MehaoHl
Coapound Asslgnaent «/PI*
< 1 (C-O) 183.99
T  1I
2 (OMOH) 169.86
3 ^NONa 3 (C-H) 132.25
4 (C-H) 127.71
5 (C-OH) 149.29
6 (C-H) 102.25
T 1 (C-O) 182.81
CHj
u 2 (ONOH) 164.97
11 3 (C-H) 131.27
3 '^ONa 4 (C-H) 126.21
5 (C-OH) 148.77
6 (C-H) 107.82
7 (CH3) 7.12
6 1 (C-O) 184.56
2 (C-NOH) 170.84
^NONa 3 (C-H) 139.59
¿H3 4 (C-H) 126.55
5 (C-OH) 148.62
6 (C-H) 101.31
7 (CHj) 16.65
*«AUh»ugh l»2*gulnonold structur« 1« «hoMn,
the r• date •re else co«p«tlble with
l,4<>qulnonold •tructur« (••• text peg« 37).
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»■■■r« SBftStZA or at MafhaoHi. Haf3-M«haoH^ and 
Ma(6-M«haoH> ¿n C^ fi
As stated above the ‘h n.n.r. spectrum of Na(hqoH) in 
d^-MSO shows that only a single species is present and 
its structure is compatible with that of Na(hqoH). In 
contrast, the spectrum of Na(hqoH) in D^O (Fig. 1.17) 
was fundamentally different to that observed in d^-DMSO, 
and did not allow any conclusions to be made regarding 
the structure of the compound in this solvent. The 
spectrum in D^ O was also recorded at different 
concentrations and temperatures, and double resonance 
decoupling experiments were carried out, but again no 
meaningful conclusions could be made.
The 'h n.m.r. spectrum of Na(3-MehqoH) in D^O as well as 
the proposed assignments are shown in Fig. 1.18. This 
spectrum is very similar to that obtained in d^-DMSO 
(Fig. 1.15) and shows the presence of only one species.
The ‘h n.m.r. spectrum of Na(e-MehqoH) in D^O is shown 
in Fig. 1.19. The spectrum contain two pea)cs at 
ca. 1.7 ppm and ca. 1.8 ppm assignable to the methyl 
hydrogen, indicating the presence of two species. In the 
aromatic region seven peaks are observed. If two 
species, both with 2 aromatic hydrogens are present, 
eight peaks (4 doublets) are expected. However, it is 
clear from the integration ratio that the three peaks at 
ca. 6 ppm result from the partial overlap of two
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doublets. This was confined by running a spectrum at a 
higher temperature. On Increasing the temperature the 
chemical shift of the peaks alter slightly revealing the 
hidden peak and the true pattern expected for two 
species Is observed (Fig. 1.20). The coupling constants 
of all pairs of peaks are identical. The value of the 
constants (9.9 Hz) Indicate that both species have a 
qulnonold structure. Furthenore. the integration ratio 
suggest that the two species are present in the ratio 
of 1:6.
The broad band decoupled spectrum (Fig. 1.21) also 
shows the presence of two species, since a total of 12 
peaks can be observed instead of the 7 peaks expected 
for a single species. This spectrum shows two peaks 
assignable to quinonold carbons at 186.8 ppm and
186.1 ppm. Although two qulnonold carbons are observed, 
only one oxlmlc (166.0 ppm) and one hydroxylic 
(148.8 ppm) carbon is observed. This suggest that the 
chemical shifts of the qulnonold and oxlmic carbons of 
the two species are identical. The observation of two 
quinonoid carbon peaks suggest that both species are 
oximic in character. As noted in Scheme 1.2 there are 3 
possible oximic Isomers for
5-hydroxy-6-methyl-l,2-benzoquinone 2-oxlme. on the 
basis of the available information It is not possible to 
define the exact structures of these Isomers. However, 
the presence of two oxlmlc isomers Is novel. Previously
46
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SINGLE CRYSTAL X-RAY STRUCTURE OF 
3-HYDROXY-2-METHYL-l,4-BENZOQUINONE 4-OXIHE
2.1 Introduction
As discussed in Chapter 1 quinone nono-oximes can have 
various structures and in solution may exhibit 
nitrosophenol/quinone oxime tautomerism. In the past a 
number of 1,2- and 1,4-quinone mono-oximes have been 
studied by X-ray crystallography.’"’ However, the 
present investigation is the first study of a guinone 
mono-oxime which could exist either as a 1,2- or a 
1,4-guinone mono-oxime (Fig. 2.1a and 2.1b 
respectively).
CH, CH,
HO>
a b
Fig. 2.1
2.2 Crystal Data for 3-Hydroxy-2-methyl-l,4-benzoguinone 
4-Oxime
C^H^NOjH^O, M = 171.09, a -  3.931(2), b -  13.741(3), 
c » 14.214(3), a - T » 90.00®, fi = 92.08°, 
U «= 767.27 F(OOO) = 320.00, (i(Mo-K^) = 4.84 cm ,
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Z - 4, D - 1.32 gem .
2.3 Crymtml Preparation and Data Collection
5-Hydroxy-3-methyl-l,4-benzoquinone 4-oxime was 
synthesized by nitrosatlon of 3-hydroxy-2-methylphenol 
using amyl nltrlte/sodlum ethoxide followed by 
acidification of the resultant sodium complex. The 
precipitate obtained from the acidification reaction was 
recrystalised from methanol/water (2:1). The crystal 
selected for the X-ray study had dimensions of 
0.40 X 0.24 X 0.24 mm. The data was collected on a 
Philips PWllOO diffractometer in the 0-range 3 - 25°, 
with a scan width of 0.8°. Using a graphite 
monochromated Mo-K^ radiation source, a total of 1353 
unigue reflections with I > 3tr(I) were collected. The 
intensity relationship I ■ i - • I- - « I—  
observed for selected strong reflections confirmed the 
presence of a primitive monoclinic crystal system. The 
data was corrected for Lorentz and polarization effects 
but not for absorption.
2.4 Structure Solution and Refinement
Systematic absences in the data of the type; OkO; 
h « 2n + 1 and hOl; i « 2n + 1 indicated that the 
crystal had crystallized in the centrosymmetric space
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group P2^c. This was subsequently confirmed by complete 
structure solution in this space group. The structure 
was solved by direct methods using the MULTAN 77 
program. ‘ This initially involved using the observed 
structure factors to statistically calculate several 
electron density maps. Careful study of these maps 
enabled the location of all the non-hydrogen atoms, 
while successive difference Fourier synthesis revealed 
the positions of all but the two hydrogen atoms of the 
water molecule. A full-matrix least-squares refinement 
minimising Z w(F - F )* was then performed using theO C
SHELX 77 program.’ All non-hydrogen atoms were refined 
anisotroplcally and all hydrogen atoms isotropically 
using w •= 2.6734/[cr^(F) + 0.000787F^] as the weighting 
scheme. At convergence R and R^  were 0.065 and 0.068 
respectively.
2.5 Discussion
All atomic co-ordinates, temperature factors, structure 
factors, bond lengths and Intra bond angles are given in 
Appendix 1.
Selected bond lengths and bond angles for 
3-hydroxy-2-methyl-l,4-benzoquinone 4-oxime are shown in 
Fig. 2.2 and Fig. 2.3 respectively. Molecular packing is 
shown in Fig. 2.4.
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Comparison of the bond length of the CO group In the 
structure of 3-hydroxy-2-methyl-l,4-benzoquinone 4-oxlme 
(Fig. 2.2) to those tabulated for compounds with 
established gulnone mono-oxime structures in Table 2.1 
shows that the bond C(4) - 0(3) (1.247(5) A] is within 
the range quoted for compounds (I - V) . The bond length 
of N - 0(1) [1.364(6) A] is also very similar to those 
reported previously. The C-N bond length of 1.284(6) A 
appears to be in the upper range of bond distances 
reported for the related structures shown in Table 2.1. 
Furthermore, the C*=N and N-0 bond distances are similar 
to those found in oximes, e.g. acetoxime'“ (C=N, 1.29 A; 
N-O, 1.36 A) whereas the C>0 bond is similar to those in 
quiñones, e.g. 1,4-naphthoqulnone'’ (1.21 A). The single 
bond character in the bond C(2) - 0(2) [1.341(5) A] is 
apparent with this bond being 0.094 A longer than the 
bond C(4) - 0(3) .
The C-C bond distances of the ring show that two C-C 
bonds are markedly shorter than the remaining four C-C 
bonds (Fig. 2.2). The short bonds are C(2) - C(3) and 
C(5) - C(6) . The mean bond length of these two short 
bonds (1.327 A) is 0.122 A shorter than the mean of the 
four remaining C-C bonds within the ring. This indicates 
that the bonds C(2) - C(3) and C(5) - C(6) have more 
double bond character than the remaining ring C-C bonds. 
Interestingly, these data show that the double bonds are
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1>4 with respect to each other rather than 1,2 as 
observed for coiipounds I - V listed In Table 2.1.
The Fig. 2.4 shows the molecular packing of the crystal. 
Two kinds of Intermolecular hydrogen bonds
[0(1)-H(01) 0(3) and 0(2)-H(02)•• 0(W)] have been
confirmed In the structure (See Appendix 1, Table 5) . In 
addition the short contact distances, 0(W)--N and 
0(W)-0(3) (2.981(6) and 2.844(6) A respectively]
Indicate the Involvement of the water molecule In the 
formation of the hydrogen bonds 0(W)-(H)--N and 
O(W)-H-•-0(3), which contribute further to the
stabilization of the structure.
From Table 2.2 It can be seen that In
3-hydroxy-2-methyl-l,4-benzoqulnone 4-oxlme all 
non-hydrogen atoms except 0(1) are planar to within 
0.02 A. However 0(1) lies at a small but significant 
distance out-side the least square plane. This can be 
attributed to the Involvement of this atom In the 
hydrogen bond 0(1)-H(Ol)• • 0(3) (See Appendix, 
Table 5).
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Table 2.2 Least Squares Plane for 3-Hvdroxv-2-Matihvl-
1.4-Benzoaulnone 4-OxlBe
C(1) -0.002(4)
C(2) -0.006(4)
C(3) 0.009(4)
C(4) -0.005(4)
C(5) -0.002(4)
C(6) 0.005(4)
C(7)* 0.017(9)
•N 0.012(8)
0(1)* 0.036(9)
0(2)* -0.001(7)
0(3)* 0.003(7)
not Included In th« cnlcuUtlon of tho piano
The results show that the compound has qulnone oximic 
rather than nitrosophenolic character. Additionally, the 
compound has the 1,4- rather than the 1,2-quinone oxime 
structure. In summary, this is indicated by the 
following:
(i) A hydrogen atom is bonded to the oxygen of the 
NO group but no hydrogen is bonded to 0(3).
(ii) Two short [C(2)-C(3), C(5)-(C6)] and four long 
carbon-carbon bonds.
(iii) Short CO and CN bond distances.
66
2.6 References
1 C. Römers, ilcta Crystallogr. , 1964, 17, 1287.
2 G. W. R. Bartindale, M. M. Crowder, and K. A. Morley, 
Acta Crystallogr., 1959, 12, 111.
3 J. C. A. Boeyens, J. Cryst. Mol. Struct. , 1976, 6,
217.
4 H. Saarinen, J. Korvenranta, and E. Näsäkkälä, Acta 
Chem. Scana., Ser. A, 1977, 31, 213.
5 H. Saarinen, J. Korvenranta, and M. Nasakkala, Finn. 
Chem. Lett., 1977, 47.
6 C. Römers and E. Fischmann, Acta Crystallogr.,
1960, 13, 809.
7 J. W. L. van Oijen and C. Römers, Acta
Crystallogr., 1966, 20, 169.
8 P. Main, L. Lessinger, H. M. Woolfson, G. Germain and 
J. P. Declerq, 'A system of computer programs for the 
automatic solution of crystal structures from X-ray 
diffraction data,' Universities of York, England, and 
Louvain-La-Neuve, Belgium, (1977).
9 G. M. Sheldrick, 'Program for crystal structure 
determination,' University of Cambridge, England, 
(1976).
10 A. Chakravorty, Coord. Chem. Rev., 1974, 13, 1.
11 P. J. Gaultier and C. Hauw, Acta Crystallogr. , 1965, 
18, 179.
67

IKON COMPLKXES OP 3-HYDROXY-l,2-BENZOQUINONE HONO- 
OXIHES AND N-ACETYL-5-AMINO-l,2-BENZOgUINONE 2-OXIME
3.1 Introduction
Iron complexes of 1,2-quinone mono-oximes have been 
known for a considerable length of time. These chelating 
agents have been used as analytical reagents for the 
determination of iron’’^ and their iron complexes have 
been used as dyes.^'* A naturally occurring iron complex 
of the 1,2-quinone mono-oxime, 4-ethenylphenyl
4-hydroxy-3-nitrosobenzoate, known as ferroverdin^’* has 
been isolated from Streptomyces sp. strain Wak. A-305 
(see Chapter 4).
3.2 Preparation of Iron Complexes of 1,Z-Qulnone 
Mono-oximes
There are three main methods for the preparation of 
iron complexes of 1,2-quinone mono-oximes:
(i) Direct method
(ii) Nitrosation method
(iii) Metal carbonyl method
Pirggt Method
This method involves the reaction of a 1,2-quinone 
mono-oxime with an Iron(II) or an iron(III) salt
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(Reaction 3.1). * The applicability of the nethod is 
lieited by the small number of 1,2-qulnone mono-oximes 
which are readily available. Generally the reaction with 
Iron(IlI) salts leads to mixtures of iron(II) and 
iron(III) complexes. The reaction with iron(II) salts, 
affords only iron(II) complexes.
n»2  or3
Fe
Nitrosation Method
As noted earlier transition metal complexes of
1,2-quinone mono-oximes are readily obtainable by the 
reaction of phenols with sodium nitrite/acid in the 
presence of a transition metal salt. This route has 
proved useful for the synthesis of a variety of iron 
complexes such as Fe(2-nqo)^, Fe(3-MeOqo)^ and 
Na[Fe(3,4-DiMeqo)^]Generally the reaction leads to 
mixtures of iron(II) and iron(III) complexes 
irrespective of the oxidation state of the iron salt
used. 10,11
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Metal Carbonyl Method
This method has been used to synthesize complexes of 
Iron(II) derived from 5-methoxy-l,2-benzoquinone 
2-oxlme and the mono-oximes of
1,2-naphthoquinone (e.g. Reaction 3.2)
CHjO^ CH3O
Fe(CO)g rrv.
•NOH
o,
Reaction 3.2
3.3 The structure of Iron Complexes of 1,2-Ouinone 
Mono-oxlmes
The donor atoms in 1,2-quinone mono-oxlmes can bond to a 
metal ion in several ways. Chelation nay involve the 
quinone oxygen and either the nitrogen (Fig. 3.1a) or 
the oxygen (Fig. 3.1b) of the NO group. Another 
possibility is for the metal to co-ordinate via the 
oxygen and the nitrogen of the NO group (Fig. 3.1c). 
Examples of complexes whose structures have been 
determined by X-ray crystallography are shown in 
Table 3.1. In all cases except the uranyl complexes of
1,2-naphthoqulnone 2-oxlme and 1,2-naphthoquinone 
1-oxime, the bonding involves chelation through the
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oxin« nitrogen and the quinone oxygen, (Fig. 3.1a). In 
the case of the uranyl complexes the bonding occurs 
through the NO group only (Fig. 3.1c). To-date, 
co-ordination via the oxygen of the NO group and the 
quinone oxygen (Fig. 3.1b) has not been observed.
.m :
Fig. 3.1
Metal chelates derived from 1,2-quinone aono-oxlmes have 
been represented in valence bond terns as a resonance 
system (e.g. Fig. 3.2) involving riltrosophenolic
(Fig. 3.2a) and quinone oximlc (Fig. 3.2b) structures. 
However, the complexes are essentially quinone 
mono-oximic in character as indicated by X-ray 
crystallographic studies of several metal complexes. 
Selected bond lengths for some complexes are shown in 
Table 3.1. The observed pattern of two short and four 
long carbon-carbon bond distances show that the quinone 
oxinic form makes a significant contribution. Further
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evidence for quinone oximlc contribution can be obtained 
from consideration of the C-N and C-O bond lengths. The 
C-N and C-O bond lengths of these complexes are 
comparable to those found in complexes containing 
oximino’* (C=N; ca. 1.40 A) or carbonyl”  (C=0; 1.28 A) 
groups respectively. This is indicative of the 
contribution from the guinone oximic structure. Similar 
features can be observed in the ferroverdin complex.
Fig. 3.2
3 ^  Previous Work on Iron Complexes of 1,2-Quinone 
Mono-oximes
A survey of the literature shows that a range of iron 
complexes of 1,2-quinone mono-oximes have been 
synthesized. These complexes and the methods used for 
their preparation and characterisation are presented in 
Table 3.2.
Complexes of type Fe(qo)^ have been prepared by the 
direct reaction of iron(III) chloride with 1,2-quinone
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Bono-oxiaes and by the nitrosation of phenols In the 
presence of Iron(IIl) chloride. The compounds obtained 
by both routes were shown to have Identical X-ray powder 
diffraction patterns and l.r. spectra as well as similar 
elemental analysis.^ It was also shown that these 
Iron(III) chelates react with alkali metal Iodides 
(Reaction 3.3), sodium acetate (Reaction 3.4) or sodium 
nitrite (Reaction 3.5) to give Iron(II) compounds of 
type Fe(qo)^ or M(Fe(qo)j) where M = Na or 
Generally the Iron(III) chelates are brown in colour 
whereas the iron(II) compounds are green In colour.
2Fe(qo)^ + 2MI MeOH 2M[Fe(qo)j] + I^
(M > Na or K)
Reaction 3.3
Fe(qo)^ + C^H^COjM
MeOH/H O
M[Fe(qo)^] + (C^ H^ CO^ ] '
(M •= Na or K)
Reaction 3.4
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F«(qo)j + NaNO^
MeOH/H, O
Fe(qo)^ + Na(qo) + [NOJ'
Reaction 3.5
It has been shown that Iron(III) chelates react readily 
with pyridine to form iron(II) pyridine adducts of type 
Fe(qo)j'2py. This observation has been rationalised in 
terms of an Internal redox reaction (Scheme 3.1).'^ 
Later work showed that other Lewis bases such as 
dimethylsulphoxlde and acetone are also capable of 
inducing internal redox behaviour.*“
Iron(II) complexes have been synthesized by both the 
direct and nitrosation methods. Two types of iron(II) 
complexes have been isolated from the nitrosation 
reactions. These are complexes of the types Fe(qo)^ or 
Na[Fe(qo)^]. The direct method usually leads to
complexes of type Fe(qo)^ but in certain cases some
iron(III) complexes of type Fe(qo)^ is also formed 10,1)
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fFe
py
Scheme 3.1
H*- abstraction 
from solvent
py
-POH
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3-5 Iron ConploKos Derived fron the Mono-oxlees of 
3-HydroxYphenol« end W-Acetyl-a-Milnophenol
3i5il Introduction
In this study several new quinone oxieic iron complexes 
were prepared using the nitrosation method from 
N-acetyl-3-aminophenol, 3-hydroxyphenol, 3-hydroxy-2- 
methylphenol and 3-hydroxy-5-methylphenol. Complexes 
have also been prepared by the direct reaction of 
iron(ll) with 3-hydroxy-l,2-benzoquinone mono-oximes.
Bsactlgn a£ 3-Hvdroxv-l.2-benzoauinone Mono-oximes 
Kittl Ammonium Ironfin Sulphate
The reaction of 5-hydroxy-l,2-benzoquinone 2-oxime 
(hqoH^), 5-hydroxy-3-methyl-l,2-banzoquinone 2-oxime 
(3-MehqoH^) and 5-hydroxy-6-methyl-l,2-benzoquinone 
2-oxime (6-MehqoH^) with ammonium iron(II) sulphate 
resulted in dark green solids of composition
and
suggested
Fe(hqoH)j-3H^O, Fe(3-MehqoH)^-2H^O
TheFe(6-MehqoH)^'2H^O respectively, 
formulations are based on analytical evidence and are 
supported by t.g.a. results (Table 3.3). The green 
colour of the complexes is in accord with the presence 
of iron in the oxidation state II. The magnetic moments 
(Table 3.3) fall in the range 3.61 - 3.94 BM and are
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Fig. 3. 3  MÿggbflUBr SMctnia ai FefhaoHt -3h o ü  la ’c
Fig. 3.4 SpgçtrwB e£ Fe(haoHi^ 3H o m  ¿ísé *£
Fig. 3.5 Mfiaateamc spsctrua at Feo-HehooHt -2h o ai 2ü *£
Fig. 3.6 Mgsgbau^r SESStrUB 2f £ef3-MehQoH>^ 2 H^ <? ziâè °£
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Fig. 3.7 Spectrum i2£ Fc(6-MehaoHl -aH^O aJ; *£
Fig. 3.8 Hossbauer Spectrum Ql Fef6-MehaoH) -2H O - ¿ M  *£
B8
lower then expected for high spin iron(II). However, 
they preclude the possibility of low spin Iron(II). The 
Mossbauer spectra (Figs. 3.3 - 3.8) of all three 
compounds show a single pair of quadrupole split peaks 
indicating that for any given compound there is only one 
type of iron site.
Previously low magnetic moments were observed for the 
complexes Fe(l-nqo)^, Fe(2-nqo)^ and Fe(5-Meqo)^ which 
were also green in c o l o u r . H o w e v e r ,  the 
Mossbauer spectra of these complexes contained two 
doublets (Table 3.4). During the course of the study the 
reaction between 1,2-naphthoquinone 1-oxlmes and 
ammonium Iron(II) sulphate was repeated several 
t i m e s . I n  each case the composition of the product 
closely corresponded to Fe(l-nqo)^. The room temperature 
magnetic moments varied from sample to sample, but each 
product reacted with pyridine to give the diamagnetic 
iron(II) complex Fe(l-nqo)-2py. All samples of the 
pyridine adduct lost pyridine quantitatively on heating 
at ca. 0.1 mm/120 ’c to give residues of composition 
Fe(l-nqo)^ which were similar to the product of the 
reaction between ammonium iron(II) sulphate and
1,2-naphthoquinone 1-oxlme. Again the magnetic 
properties of the residues varied from sample to sample, 
the Mossbauer spectra showed two doublets, and each 
sample reacted readily with pyridine to reform the
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complex Fe(l-nqo) j-2py.
These observations were explained in terms of an 
oligomeric structure for Fe(l-nqo)^ (Fig- 3-9)- The 
outer pair of peaks in the Mossbauer spectrum of this 
complex was assigned to the terminal 5 co-ordinated high 
spin iron(II) and the inner pair to the six co-ordinated 
low spin iron(II). The variation of the magnetic moments 
from sample to sample was explained as due to the 
differences in the average chain length of the oligomer. 
Similar observations and suggestions were made for the 
products Fe(2-nqo)^ and Fe(5-MeOqo)^ arising from the 
reaction of iron(ll) with 1,2-naphthoquinone 2-oxime and
5-methoxy-l,2-benzoquinone 2-oxime respectively 23
Table 3.4 Room Temperature Bógsfcaaei: ParaiBgtgrg S M  
Magnetic Moments si fSlSSi^ CgBPXsaSS
Complex a*/mm s"' A/mm s'' Ref.
Fe(l-nqo)^ 0.08
1.22
0.79
4.00
3.08 13
Fe(2-nqo)^ 0.05
1.22
0.71
3.99
3.04 13
Fe(S-MeOqo)^ 0.12
1.05
0.60
3.74
2.78 10
• R « l « t l v6 to aetAillc Iron
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The roon temp«rature nagnetic moaents of Fe(hqoH)^-3H^O, 
F«(3-MahqoH)^-2H^O and Fe(6-MehqoH)2-2H 0^ are too low 
for the iron to exist as high spin iron (II). However 
*’’2~**i crossover or antiferroaagnetic coupling of 
a high spin iron(II) systea can reduce the room 
teaperature aagnetic aoment. These possibilities are 
precluded by the Hossbauer results as discussed below.
Iron(II) complexes normally have either the (S = 2, 
high spin) or the (S = 0, low spin) configurations. 
If the energies of these two states are similar then 
both forms can coexist. A magnetic aoment in between the 
values expected for high spin (4.9 - 5.3 BM) and low 
spin (0 BM) will be observed at the vicinity of the 
crossover temperature. When the crossover temperature 
coincides with the teaperature chosen for magnetic 
moment aeasureaents then, the magnetic moment will be 
low but the Mossbauer spectra at the same temperature 
should show iron sites due to both spin states. However 
no such effect is observed for the complexes under 
discussion. Hence their abnormal aagnetic moments cannot 
be due to spin crossover.
Antiferroaagnetic coupling of a high spin iron(ll) 
species is also unlikely since the Mossbauer spectra do 
not show such a coupling at the temperatures examined. 
Furthermore, the Mossbauer parameters do not correspond
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to those expected for high spin iron(II) cospounds.
The most likely explanation for the observed nagnetic 
Bonents and Mossbauer spectra is that these compounds 
are Iron(II) complexes in which the Iron(II) exists in 
the S - 1 state.
When the symmetry is close to octahedral iron(II) 
complexes adopt either S • 2 or S > 0 electronic 
configurations. However, when the symmetry is low the 
intermediate S « 1 state can be adopted”  and has been 
observed in complexes such as [Fe(L^) F^ -4H^0) and
[FeL^(ox)-5H^0] 
oxH^ - oxalic acid)
(L - 1,10-phenanthroline
30-32
and
Significantly the room 
temperature magnetic moments of such complexes^^ 
(ca. 3.8 - 4.2 BM at 293 K) are very similar to those 
found for the complexes under discussion.
3.6 Keaction of 3-Hydroxyphenols with Sodium 
Witrite/Acid in the Presence of Ammonium Iron(II) 
Sulphate
The synthesis of iron complexes derived form 
5-hydroxy-l,2-benzoquinone mono-oximes was also 
attempted using the nitrosation method. Previously it 
has been established that 3-hydroxyphenol and 
3-hydroxy-5-methylphenol undergo di-nitrosation in the
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prasence of nickel(II) or copper(II) salts.” ’“ In both 
cases, polymeric materials of type M(dnr) xH^O (M - Ni*‘ 
or Cu**) are formed (Reaction 3.6). However, in the case 
of 3-hydroxy-2-iiethylphenol mono-nltrosatlon occurs and 
complexes of type H(6-Mehqo)2-xH20 (M - Ni^ * or Cu^ ’) 
are obtained (Reaction 3.7). In all cases the ligand 
could be liberated by acidification of the complex.
HOs -OH NaNOj/Acid
R = H orCHj 
M** = Cu** or Ni*"*"
Reaction 3.6
NaNOj/^cid
M
Reaction 3.7
The nitrosation of 3-hydroxyphenols in the presence of 
ammonium Iron(II) sulphate afforded highly insoluble
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black solids whose l.r. spectra were ill-defined. In all 
cases elesental analysis of the solids Indicated the 
presence of both iron and sodluo, but no meaningful 
formulations could be deduced. Thermal gravimetric 
analysis showed these compounds to be thermally unstable 
with a decomposition temperature of ca. 80 *C. Attempts 
to isolate the ligands by acidification of the complexes 
failed.
3.7 Reaction of M-Acetyl-3-aminophenol with Sodium 
Witrite/Acid in the Presence of Ammonium iron(II) 
Sulphate
In contrast to the behaviour of the 3-hydroxyphenols, 
M-acetyl-3-aminophenol reacted smoothly with sodium 
nitrlte/acld in the presence of ammonium iron(II) 
sulphate to give two iron complexes and an organic 
product. Thus when N-acetyl-3-amlnophenol was treated 
with sodium nitrite/acld in the presence of ammonium 
iron(II) sulphate a brown mixture resulted which changed 
into green after ca. 1-2 h. This crude green product 
contained three components, one yellow and two green, 
which were separated by column chromatography. The 
yellow product which was eluted with ethylacetate was 
identified as N-acetyl-3-amino-l,4-benzoquinone 4-oxime. 
The first green product eluted with methanol was the 
major product and was characterised as sodium
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tri*(N-acetyl-3-a«ino-l,2-benzoqulnone 2-oximato)- 
ferrate(II) tetrahydrate. The second green component was 
eluted with methanol after leaving the column filled 
with pyridine for 12 h. This component was characterised 
as bis(N-acetyl-3-amino-l,2-benzoquinone 2-oximato)- 
iron(II) dipyridlne. On the basis of the characteristic 
colours previously reported for iron complexes of
1,2-qulnone mono-oximes, l.e. brown for iron(III) and 
green for iron(II) it is reasonable to assume that 
the above reaction initially leads, at least in part to 
the formation of iron(III) complexes which subsequently 
change to iron(II) complexes. As mentioned in 
Section 3.4, such reduction involving complexes of type 
Fe(qo)^ has been observed earlier and lead either to 
complexes of types Fe(qo)^ or M(Fe(qo)^]
Both complexes, Na[Fe(N-Acqo)^]-4H^0 and Fe(N-Acqo)^-2py 
obtained from this reaction were diamagnetic. This 
agrees with previous results obtained for similar 
complexes. The n.m.r. spectra and the assignments for 
N-Acetyl-3-amino-l,4-benzoquinone 4-oxime and 
Na[Fe(N-Acqo)^)-4H^O are shown in Figs. 3.10 - 3.11. The
temperature Hossbauer spectra of
Na[Fe(N-Acqo)^]-4H^O and Fe (N-Acqo) 2py are shown in in 
Fig. 3.12 and Fig. 3.13 respectively. Hossbauer 
parameters for analogous iron(II) complexes obtained in 
previous studies are given in Table 3.5 and are similar
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9a

3.12 M^ggbttUgr SPectrUM ai MafFefN-Acao> 1-4H^0 at ia *£
Fig. 3.13 Mgggbaggr SpggtruB ai Fe(w-Acaoi^ 2pv ai ia *£
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to those obtained during the present study for the above 
two complexes.
As in the case of 3-hydroxy-l,2-benzoquinone 
mono-oximes, N-acetyl-3-amino-l,2-benzoquinone 2-oxime 
can also exist in the 1,2- or 1,4- forms (Scheme 3.2). 
The structure of the complex and especially the 
structure of the ligand in the complex is important with 
regard to the stability and other characteristics of the 
complex. This is because of the different ligand field 
effects of the chelated 1,2- and 1,4- forms. As noted 
above the magnetic moment, Mossbauer parameters and the 
colour of the iron(li) complexes of 
N-acetyl-3-amino-l,2-benzoquinone 2-oxime agree with 
those previously observed for iron(II) complexes of
1,2-quinone mono-oximes such as 1,2-naphthoguinone 
2-oxime which has no corresponding 1,4-form. Hence, it 
is likely that N-acetyl-3-amino-l,2-benzo(]ulnone 2-oxime 
also exist in the 1,2—form in its iron complexes.
■Cc' OH ^OH
I
OH
"XX
A h
X = NCOCH,
Scheme 3.2
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THE IN-VIVO STUDY OF 1,2-BENZOQUIHONE HONO-OXIHES 
AS IKON CHELATORS
4.1 Introduction
Generally, a total of 26 elements are believed to be 
essential for animal life.' The elements carbon, 
hydrogen, oxygen, nitrogen, sulphur, calcium,
phosphorus, potassium, sodium, chlorine and magnesium 
are classified as major elements as they are reguired in 
large amounts. The remaining 15 elements (iron, iodine, 
copper, manganese, zinc, cobalt, molybdenum, selenium, 
chromium, nickel, tin, silicon, vanadium, arsenic and 
fluorine) are classified as trace elements. However the 
necessity and/or physiological function of the last 6 
elements has not been identified with any great 
certainty. Out of the 15 trace elements 10 are metals. 
With the exception of sodium, potassium, calcium, 
magnesium and tin, all the other essential metals are 
transition metals.
The amount of essential metals within living systems is 
controlled by two parameters, (i) external availability 
and (11) internal physiological control mechanisms. The 
control mechanisms have the capability of maintaining 
the amounts of metals in the living system to within 
fine limits. If as a result of the diet or other 
external function, or as a result of malfunction of a 
control mechanism, the concentration of an essential
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netal becomes abnormal, then the well-being of the 
organism Is affected.
Mgtal Deficiency Disorders
In man, the most common metal deficiency is probably 
that of Iron deficiency anaemia. It has been estimated 
that in developed countries, the Incidence of iron 
deficiency in children under 3 years and women during 
child bearing years is between 20% and 30%.^ In 
developing countries, this figure is at least doubled as 
a result of poor diet and blood loss due to intestinal 
parasitism. Clinical signs associated with anaemia are 
paleness, lethargy, decreased growth, behavioural 
changes, and an increase in vulnerability to infections. 
Iron deficiency anaemia can be easily corrected in most 
individuals by oral administration of iron(II) sulphate, 
sometimes together with ascorbic acid to aid absorption.
Deficiency disorders related to manganese, copper and 
zinc are also known. The occurrence of manganese and 
copper deficiency is rather rare.’ Zinc deficiency 
disorders are however quite common and are widespread 
both in developed and the developing countries. 
Deficiency can result from either dietary factors that 
reduce zinc absorption, or as a result of the rare 
inherited disorder acrodermatitis enteropathies,^ which 
causes a partial block of dietary zinc absorption. Zinc 
deficiency has been associated with various clinical 
features including from disturbances of normal growth
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patterns, skin rashes and abnoraal sensory perception to 
behavioural abnomalltles.
Over-load Disorders
The concentration of trace metal ions in the body can 
increase as a result of: (1) poisoning, (ii) breakdown 
of the regulatory mechanism, and (iii) side effect of 
certain medical treatments. Such increases can lead to 
disorders which are referred to as metal over-load 
disorders.
Metal poisoning may arise because of dietary factors, 
pollution or as a result of exposure to metal compounds. 
A well known example of this type of metal poisoning has 
been observed in the African Bantu,* where a high 
incidence of iron over-load especially in adult males 
results from the preparation of food and alcoholic 
drinks in iron containers. Alcoholics can also suffer 
from mild degrees of iron over-load. This is because of 
the iron content of some alcoholic drinks and because of 
the alcohol-stimulated absorption of iron. Lead and 
mercury are also known to cause poisoning as a result of 
consuming food or water contaminated with these metals. 
Lead poisoning can arise in localities where the 
drinking water is soft and the water supply pipes are 
made of lead. A well documented case of mercury 
poisoning occurred in Minamata, Japan.* This resulted 
from mercury released into Minamata bay from an 
Industrial plant. The metal was concentrated along the
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food chain, and on eating the contaainated fish himans 
developed sercury poisoning.
Increase in eetal concentration due to the breakdown of 
a regulatory sechanism occurs for example, in patients 
suffering from Wilson's disease.'' in Wilson's disease 
the natural mechanism for the control of copper 
concentrations is disrupted, resulting in the 
accumulation of free copper ions in the liver, brain and 
kidneys. Up to one hundred times greater than average 
concentrations of copper have been observed in some 
patients. The symptoms of Wilson's disease include 
hepatic cirrhosis, lack of co-ordination, severe 
tremors, and progressive mental deterioration. Another 
disorder that falls within this category is primary or 
idiopathic haemochromatosis.* This is a genetically 
determined disease of iron metabolism which results in a 
increase in iron absorption. Patients suffering from the 
disease have a positive iron balance in the order of 
2 mg/day. This results in the accumulation of 20 to 30 g 
during 40 years prior to occurrence of 
symptomatic disease in later life. This includes 
cirrhosis of the liver, pituitary, adrenal, and thyroid 
failure, and eventually cardiac failure.
Occurrence of metal over-load as a secondary effect of 
medical treatment is only applicable to aluminium and 
iron. Over-load involving aluminium and iron occurs in 
undergoing long term dialysis treatment" and
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those receiving 
respectively.
Bultiple blood trsnsfusions’
Multiple blood transfusions are needed in a variety of 
inherited and acquired forms of anaemia, of particular 
importance are the haemogloblnopathies, including 
thalassaemia and to a lesser extent sickle cell 
anaemia.'® In man, there is no physiological system for 
iron excretion." Iron balance is maintained by 
regulation of iron absorption. Each unit of transfused 
blood contain about 200 mg of iron and hence, the body 
iron content (normally about 4 g in an adult) is 
increased with each transfusion.
Generally the only method of treating metal over-load is 
by chelation therapy. This involves the administering of 
a chelating agent which binds with the harmful metal and 
the metal complex is then excreted from the body in 
urine and/or faeces. For example, in the treatment of 
copper poisoning in Wilson's disease, the chelating 
agent D-penicillamine (Fig. 4.1a) is used.^ other 
examples of chelating agents are 2,3-dlmercaptopropanol 
(British Anti-Lewisite, BAL) (Fig. 4.1b) and 
ethylenediaminetetraacetic acid (EDTA) (Fig.4.1c) and 
its disodiumcalcium(II) complex. BAL has been used for 
the treatment of poisoning by arsenic, mercury, cadmium, 
gold, thallium and bismuth, and EDTA and its calcium 
complex for the treatment of lead poisoning. The use of 
the calcium complex of EDTA is preferred to counter the
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•ffect of calclua removal by the acid.^
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Ethylenediaminetetraacetic acid 
Fig. 4.1
In the case of iron over-load arising due to primary 
haemochromatosls an alternative method to chelation 
therapy is available. The accepted treatment for 
patients suffering from this disease is venesection.'^ 
However for thalassaemic patients venesection is not 
practical because of the inherent anaemia. Hence in 
these patients the only method of removing iron is by 
chelation therapy. At present the main drug used for 
iron chelation therapy is desferrloxamlne (Fig. 4.2).’
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Fig. 4.2
Syndromes
Thalassaemlas are an Inherited group of disorders of 
haemoglobin, which are characterised by a reduced rate 
of synthesis of one or more of the globln chains of 
haemoglobin.’ This leads to a reduction in the amount of 
haemoglobin synthesized as well as to unbalanced globin 
chain synthesis, with the resultant precipitation of 
those chains which are produced in excess. Thalassaemlas 
can be classified according to which particular globin 
chain is synthesized ineffectively, i.e. into a, fi, Sfi, 
S, and jSfi thalassaemias. Additionally they can also be 
classified according to their clinical phenotypes. 
Usually the clinical and molecular classifications are 
combined. Thus homozygues p-thalassaemia usually gives 
rise to a severe transfusion dependent form of 
0-thalassaemla called 0-thalassaemla major, but a 
proportion of homozygotes have a less severe but 
symptomatic form called 0-thalassaemla intermedia. The 
asymptomatic heterozygous carrier state is called
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0-thalassaemla trait.
Thalassaemia has a world-wide distribution. It is 
especially comnon in the Mediterranean region, parts of 
the Middle-East, India, PaXistan, and in South-East 
Asia, and particularly Thailand. The reason for the high 
Incidence of E-thalassaemia genes in some populations is 
not fully understood, although there is some evidence to 
show that carriers are more resistant to Plasmodium 
falciparum malaria infection.'" The percentage of the 
population who are carriers of thalassaemia vary from 
country to country. It is estimated that world-wide 
about 100,000 severely affected homozygotes are born 
each year,'" and thalassaemia is a major public health 
problem in the Mediterranean regions and particularly in 
South-East Asia. Application of molecular biological 
techniques to antenatal diagnosis combined with 
antenatal screening and counselling is leading to a 
dramatic decrease in new homozygote births in several 
European countries. However, large numbers of patients 
will continue to require regular blood transfusions with 
inevitable Increase in their iron load.
4.2 Chelators for the Treatment of Iron Over-load
Before proceeding further it should be noted that 
ideally, a chelator used in the treatment of metal 
over-load should have the following properties:
(i) low toxicity.
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(il) chealcal stability,
(iii) ability to fora a stable, non-toxic cosplex 
with the target netal which can be excreted 
rapidly in urine and/or faeces,
(iv) activity after oral administration,
(V) specificity for the target metal, i.e. must not 
cause the excretion of other essential metals, 
(vi) ability to penetrate into the tissue deposits 
of the target metal.
Desferrioxamine, the main drug used at the present time 
for the treatment of iron over-load was introduced in 
I960.** It is a siderophore produced by the yeast 
Streptomyces pilosus. Desferrioxamine was first used in 
the treatment of acute iron toxicity that results from 
accidental ingestion of iron tablets. In the I970's it 
was shown that intra-muscular injections of this drug 
slows down iron accumulation in thalassaemic patients.
It was also found that administration of ascorbic acid 
to these patients could substantially increase the 
quantity of urinary iron excretion caused by 
desferrioxamine.** It was also established that for 
maximal iron excretion, prolonged intra-venous infusion 
of desferrioxamine is necessary. However, this technique 
was found to be impractical on a daily basis and a 
method of subcutaneous infusion by use of a micro-pump 
was introduced.*^
With a few exceptions, only minimal toxicity has been
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observed with desferrioxasine. Minor side effects that 
have been observed include abdominal pain, lowering of 
blood sugar, diarrhoea and fever. In some instances 
however, particularly when large doses of 
desferrioxamine have been infused into patients with 
only modest degrees of iron over-load, serious ocular 
and auditory toxicity have been observed.
There are two major disadvantages to the use of 
desferrioxamine. These are (i) ineffectiveness of the 
drug when given orally and (ii) high expense of the 
drug. The need for daily subcutaneous Infusions leads to 
high non-compliance, especially amongst teenagers. 
Efforts to modify desferrioxamine so as to make it 
orally active have been unsuccessful. The high cost of 
the drug is also a problem, especially in developing 
countries. For example, it has been estimated on the 
basis of 1983 prices that to supply the drug to 300 
patients in the U.K. would cost $ 1.6 million for the 
purchase of the drug alone.*’ However additional 
expenses for micro-pumps, syringes and other disposables 
increase the cost substantially.
Another possible disadvantage of desferrioxamine relates 
to its specificity towards iron. As noted earlier 
ideally, a chelating agent used in the treatment of iron 
over-load should only cause the excretion of iron since 
excretion of other biologically essential metals can 
lead to harmful effects. In the case of desferrioxamine
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thar* have been contradictory reports about Its effect 
on the excretion of biologically Important metals other 
than iron.“ ”“  It has been suggested that the ocular 
toxicity of desferrioxanine may arise as a result of 
chelation of copper.”
Because of the disadvantages of desferrioxanine there is 
a need for an alternative drug; A new drug for the 
treatment of iron over-load should comply with the 
general criteria listed earlier and in particular should 
be: (i) orally active, (ii) non-toxic, and (iii) cheap.
Several research groups are currently involved in the 
synthesis and study of alternative drugs for the 
treatment of iron over-load. Most of the compounds 
studied are modelled on naturally occurring siderophores 
but other simple chelating agents have also been 
Investigated. Siderophores are iron chelators excreted 
by microbes under conditions of iron deficiency.“  The 
siderophores have been developed by micro-organisms to 
counteract the high insolubility of iron hydroxide 
» 10"“ ) at physiological pH. The micro-organisms 
synthesize and excrete siderophores into the surrounding 
environment where they complex with iron. Various 
methods have been developed by micro-organisms to 
up-taXe these iron(III) siderophore complexes.“
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Fig. 4.3
Although there are considerable variations in the 
siderophores, the donor atoms are usually oxygen 
belonging to the hydroxamate (Fig. 4.3a) or catecholate
(Fig. 4.3b) groups 7,26 However, there are several
exceptions which utilise mixed forms of co-ordination. 
Generally the catecholates are utilised by bacteria 
whereas the hydroxamates are utilised by higher 
organisms such as yeasts and fungi. Examples of 
different types of siderophores are illustrated in 
Fig. 4.4. Most of the naturally occurring hydroxamic 
acid siderophores have three hydroxamic groups per 
molecule and hence form neutral iron(III) complexes with 
an iron to ligand ratio of 1:1. Examples of this type 
are the ferrichromes and the ferrioxamines. Ferrichromes 
consist of a cyclic peptide moiety with three hydroxamic 
acid side chains, while in ferrioxamines the hydroxamic 
groups are part of a linear or cyclic molecule. 
Rhodotorulic acid is also a hydroxamic acid siderophore. 
However this compound has two hydroxamic groups per 
molecule and forms 2:3 (metal:ligand) complexes with 
iron(III) at pH 7.“  Examples of catecholate 
siderophores are itoic acid and enterobactin. 
Enterobactin forms a negatively charged 1:1 iron(III)
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coaplcx. Nycobactin and aarobactin are exaaples of 
siderophores which utilise nixed forms of co-ordination. 
Mycobactin co-ordinates via two hydroxamate groups, a 
phenolate group and an oxazoline nitrogen, whereas in 
aerobactin two hydroxamate groups and a 
o-hydroxycarboxylate group are utilised. Recently it has 
been shown that in rhizobactin (Fig. 4.4) a siderophore 
produced by the bacterium Rhizobium melllotl DM4, the 
metal is co-ordinated via the 
ethylenediaminedicarboxylate and o-hydroxycarboxylate 
moieties. Hence uniquely contain neither hydroxamate nor 
catecholate groups.“
To date, a considerable number of compounds have been 
tested for their suitability as orally active iron 
chelators. A large portion of the these compounds are 
either naturally occurring siderophores or synthetic 
siderophore analogues. A selection of chelators that 
have been tested on humans and/or animals are listed in 
Table 4.1. 2,3-Dimercaptopropanol (BAL), disodlum 
N-hydroxyethyl(ethylenediaminetriacetate) (Na^HEDTA), 
and ethylenediaminetriacetic acid (EDTA) were found to 
cause very little iron excretion.“ ’“  In addition, for 
EDTA toxic effects were observed. The quantity of iron 
excreted as a result of intravenous Infusion of 
ethylenediamine-N,N '-bis(2-hydroxyphenylglycine) (EHPG) 
was in excess of that required to maintain iron 
balance.**'^* The only side effect reported in humans 
was polyurea,however in animals other side effects
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hav« been observed. 2.3-Oihydroxybenzoic acid 
(2,3-DHB), although orally active and of low toxicity 
causes too little iron excretion to have any effect on 
the rate of iron build-up in the liver.” '“ In contrast 
rhodotorullc acid causes higher rates of iron excretion 
than desferrioxamine, however it has a number of serious 
disadvantages. These are increased urinary excretion of 
zinc, intense pain and swelling at the site of 
injection, and ineffectiveness when administered 
orally.” ’“  Similarly dlethylenetriamlnepentaacetic 
acid (DTPA) was also found to be orally inactive as well 
as being non-selectlve for iron.“ '” ’“  This compound 
causes the excretion of calcium, magnesium, zinc, 
manganese and copper. Despite these side effects DTPA 
has been used in cases where the patients are allergic 
to desferrioxamine. Recently 1,2-dimethyl-3- 
hydroxypyrid-4-one has been tested as an iron chelator 
in man.*' The compound was found to be orally active. 
However, toxic effects have been observed in animals and 
in man. Toxic effects observed in animals are 
hypersalivation, ocular toxicity and reduction in white 
cell c o u n t . I n  addition, agranulocytosis and 
thrombocytopenia have been observed in a female patient 
undergoing treatment with this compound.“  Other 
derivatives of 3-hydroxypyrid-4-ones which are less 
toxic (e.g. l-ethyl-2-methyl-3-hydroxypyrid-4-one) are 
also under investigation.*^
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4.3 In-vlvo Scr4enlnq of Potential Iron Chelators
<.3il TYPgg SX Chelators Investigated
In this study three related types of quinone mono-oxlDlc 
chelators (Fig. 4.5a-c) were Investigated with regard to 
their ability to remove Iron ln~riyo. These chelators 
were selected because such compounds are known to have a 
strong affinity for Iron. A compound containing this 
type of chelator Is found In the naturally occurring 
ferroverdin (Fig. 4.6). This Is produced by Streptomyces 
sp. strain Wak. A-305.**”*^  A further reason for the 
choice of quinone mono-oximes for this study was the 
ability of these compounds to chelate Iron(II). Although 
quinone mono-oxlmes form chelates with both iron(II) and 
iron(III), their affinity for iron(II) is greater. 
To-date most compounds that have been tested have been 
Iron(III) chelators. Two iron(II) chelators that have 
been tested, 2,2'-dipyridyl and 1,lO-phenanthroline, 
cause moderate amounts of iron excretion, suggesting the 
possible existence of an accessible pool of iron(II)
The chelators (Fig. 4.7) were administered in the form
1 2 4
Anion of Ferroverdin 
Fig. 4.6
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of sodlun coaplaxas except in the case of 
N,N-dimethyl-5-aBlno-l,2-benzoquinone 2-oxlne where the 
hydrochloride salt was used. These derivatives rather 
than the free ligands were used because of their higher 
solubility in water.
OX X
hqoH:
3-MehqoH: Rj=H,
6-MehqoH: R -CH , R -H
1 3 2
Fig. 4.7
4.3.2 In-vivo Evaluation ai îiis Oximic Iron Chelators
In earlier studies both in-vivo and in-vitro methods 
have been used for the assessment of iron chelators. Two 
in-vitro models that have been proposed are the 
hepatocyte culture*^ and the Chang liver cell culture*^ 
models. The hepatocyte culture model involves trace 
labelling of primary hepatocyte cultures from male 
Wlstar rats with *’Fe-transferrin followed by incubation
126
of these cells with the test chelator. The effectiveness 
of the chelator is detemined by the amount of Iron 
mobilised into the culture medium. In the Chang liver 
cell culture model the effectiveness of the chelator is 
determined by measuring the Inhibition of iron uptake 
and ferritin synthesis by the cells. In addition an 
in-vitro model based on heart cell cultures has also 
been proposed.
A number of in-riro animal models have also been 
proposed. These models are based on either iron 
loaded^^’“ ”“  or normal animals.^’’” The main 
disadvantages of the in-ritro models are their inability 
to assess the oral activity and the iron selectivity of 
the test chelator. However in-riro models based on iron 
loaded animals involve prolonged and inherently 
inaccurate iron balance studies. Hence a normal iron 
replete animal model^’ was chosen for this study. The 
protocol for this model is Illustrated in Scheme 4.1. 
The rats were first injected with “ Pe-ferritin through 
the lateral tail vein. After 1.5 h the test chelator 
was administered, either orally or as an intra-muscular 
injection. The urine and faeces were collected 
separately for 4 h. At the end of this period, the 
animals were sacrificed by exsanguination followed by 
perfusion with normal saline prior to removal of the 
organs. Gamma counting was carried out on various organs 
as well as on blood, urine and faeces to determine the 
amount of *’pe present. The urine was further analysed
127

by atomic absorption spectroscopy for magnesium, 
calcium, iron, copper, and zinc.
It has been shown that the 7.5 yg dose of ferritin radio 
iron used in this model is cleared rapidly from blood 
and that after 2 h. about 94 t of the *^Fe was in the 
l i v e r . I t  has also been shown that there is a “time 
window“ of maximal availability of ’^Pe to the chelator. 
The “time window“ is between 2-6 h after the Injection 
of ®’pe-ferritin. To account for this observation it has 
been suggested that the iron is available to the 
chelators while in transit within the hepatocyte and 
that once the iron is Incorporated into endogenous 
ferritin it becomes relatively unavailable.”  The ratio 
between ” pe and total iron excreted (the specific 
activity) in bile was constant irrespective of the wide 
range of total iron excretion produced by different 
doses of desferrloxamlne. Furthermore in iron loaded 
rats, the specific activity was lower than in normal 
rats. This indicate that the ” Fe-ferritin is uniformly 
labelling a pool of chelatable iron within the 
hepatocyte.
The results of the ” Fe-ferritin study are presented in 
Table 4.2. These Indicate that:
(i) None of the test chelators are successful in 
causing iron excretion when administered 
orally.
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(ii) with the exception of Na(hqoH) and 
Na(6-NehqoH), none of the chelators cause iron 
excretion when administered intra-muscularly.
(iii) Na(6-NehqoH) causes more iron excretion than 
Na(hqoH) when administered by intra-muscular 
injection, though less than in the case of 
desferrioxamine.
Iron content determination in urine (Fig 4.8} by atomic 
absorption showed similar results to urine **Fe 
determination experiments. This indicates that the 
chelators are not causing the urinary excretion of iron 
from an iron pool which has not been labelled by ’^Pe.
In separate experiments, the Fe(III)-chelates were 
administered to rats by stomach tube (Scheme 4.2). The 
purpose of these experiments was to investigate whether 
the chelate would be absorbed in the gut. If a chelator 
is to successfully remove iron from the body by 
excretion of the iron complex in faeces then the complex 
must not be reabsorbed during its passage through the 
gut. The results (Table 4.3) indicate that in all the 
cases over 80% of the administered complex is found in 
the gut and faeces after 48 h. The highest absorption 
occurs in the case of sodium
5-hydroxy-6-methyl-l,2-benzoquinone 2-oxlmate
Na(6-MehqoH). The absorbed iron appears in the blood and 
the carcass. In general, it can be concluded that for
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the ligands tested no Major absorption of the 
Fe(III)-chelate occurs.
The results of the urinary excretion of magnesium, 
calcium, copper and zinc are presented in Fig. 4.9-4.12. 
Except for the case of intra-muscularly injected 
N-Me^qoH.HCl, the charts indicate the total weight of 
metal excreted during the 4 h urine collection
(Scheme 4.1). Since the animals died within 1 h of 
injecting N-Me^qoH.HCl, the metal excreted up to the 
time of death is presented. The results show that 
magnesium excretion is increased for all test chelators 
Irrespective of the route of administration. In contrast 
all test chelators caused the retention of calcium. It 
has been reported that desferrioxamlne causes the 
retention of magnesium and calcium in rats.^^ During the 
present study a similar effect was observed for calcium 
both at the 20 mg and 40 mg dose levels, but no 
alteration of the magnesium excretion was observed. Zinc 
retention was observed for all the test chelators except 
N-AcqoH for which normal levels of excretion was 
observed. No alteration of the urinary excretion of 
copper or zinc was observed for desferrioxamine. The 
copper excretion was normal for all test chelators.
Although no systematic assessment of the toxicity of the 
chelators were carried out the results allow some 
conclusion to be drawn regarding their relative 
toxicity. No toxic effects were observed for Na(N-Acqo),
1 34





HaH^Va and Na(3-HehqoH) except stoaach distension in 
cases where Na(3-MehqoH) was administered orally. The 
compounds Na(hqoH), Na(6-MehqoH) and N-Me^qoH.HCl caused 
hypersalivation. However in the case of Na(hqoH) this 
effect was only observed when it was administered 
intra-muscularly. This phenomenon has also been observed 
in the case of l,2-dimethyl-3-hydroxypyrid-4-one which 
as mentioned previously causes hypersalivation in 
rats.*^
N-Me^qoH.HCl was the most toxic of the chelators tested. 
Within 0.5 h of administering the drug, hypersalivation 
occurred. The intra-muscularly injected rats started to 
convulse within 0.75 h of injection and died within an 
hour.
Addition of iron(II) sulphate to a aliquot of urine from 
rats administered with Na(hqoH), Na(3-MehqoH), 
Na(N-Acqo), or N-Me^qoH.HCl gave a green colouration. 
Urine of rats administered with NaH^Va gave a blue 
colouration. These colours are characteristic of the 
iron(II) complexes of these chelators and is indicative 
of the presence of unmetabolized chelators in urine. 
Additionally, the presence of the unmetabolized 
chelators were further established by comparative thin 
layer chromatography.
From the chelators tested, the only compound that caused 
the excretion of iron to any great extent was
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EXPERIMENTAL
5.1 Reagents end General Techniques
The reagents and solvents employed were obtained 
commercially and used without further purification. The 
silica gel absorbent used in the chromatography columns 
was Merck silica gel 60 (70 - 230 mesh) and the ion
exchange resin used was Dowex 50H-X8(H) supplied by BDH 
Chemicals Limited. Thin layer chromatography was
performed using commercially supplied silica coated 
alumina plates.
5.2 Analytical Techniques
Magnesium, calcium, iron, copper and zinc in urine was 
determined quantitatively by the method of atomic 
absorption spectrometry, using a Pye-Unicam SP9 atomic 
absorption spectrometer. After centrifugation to remove 
any urinary sediment present a known volume of urine was 
warmed in a mixture of concentrated nitric
acid/perchloric acid /sulphuric acid (3:1:1) (ca. 4 cm’) 
and 30» hydrogen peroxide (ca. 1 cm’). After allowing 
the mixture to digest, the inorganic residue was diluted 
to a known volume with water.
Sodium, potassim, calcium and iron in samples of metal 
complexes were also determined by the method of atomic
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absorption spsctrometry. A k o w  aass (ca. 0.2 g) of the 
material under investigation was warmed with 
concentrated sulphuric acid (ca. 1 ca^), concentrated 
nitric acid (ca. 2 cm’) and hydrogen peroxide 
(ca. 1 cm’) . After allowing the mixture to digest, the 
inorganic residue was diluted to a known volume with 
water.
Carbon, hydrogen and nitrogen analysis were carried out 
on a Carlo Erba 1106 elemental analyser.
5.3 Physical Techniques
Infra-red Spectroscopy. —  Infra-red spectra in the 
region 4000 - 400 cm”’ were recorded on a BIO-RAD FTS40 
spectrometer. The samples were prepared as pressed 
potassium bromide discs.
Nuclear Magnetic Resonance Spectroscopy. —  Fourier 
transform *H and ”c n.m.r. spectra were recorded on a 
Bruker AM250 or on a Joel 270 MHz spectrometer. 
Trimethylsilane was used as an Internal standard for 
spectra recorded in d^-C«S0 and it was used as an 
®xternal standard in the case of spectra recorded in
Magnetic Measurments. —  Room temperature magnetic 
moments were recorded using a Johnson Matthey magnetic
ISO
susceptibility balance. The instrunent was calibrated 
with a solution of aanganese(II) chloride. Magnetic 
moments were corrected for the diamagnetic effect of the 
metal and the ligands.'
Hossbauer Spectra. —  A Cryophysics Hossbauer spectrometer 
with a ” co/(rhodium) source and a CO^Xe detector was 
used to record the Hossbauer spectra at 20 ‘c and 
-196 ’ c.
Thermal Gravimetric Jlnalysis. —  Thermal gravimetric 
analysis was carried out on a Stanton HT-SM
Thermobalance.
5.4 Reactions
5.4.1 Reaction s£ 3-hvdroxvphenols 11 BI2I equiv) wiih 
aravl nitrite and sodium ethoxide H  BSl gquivl ai
Sodium (4.60 g, 200 mmol) was dissolved in dry ethanol
(200 cm^ ) and the solution was cooled to -10 °C. To this
solution 3-hydroxyphenol (22.00 g, 200 mmol) was added, 
followed by portlonwlse addition of amyl nitrite
(25.74 g, 220 mmol) over a period of 1 h. The reaction 
mixture was allowed to reach 20 °C over a period of 2 h
and then filtered to give orange sodium
5-hydroxy-l,2-benzoquinone 2-oximate monohydrate
(31.83 g, 89%) which was washed with ice cold water
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(30 c* ), ethanol
(b.p. 30 - 40 C) 
0.1 ibib/50 *C.
(30 C»"), 
(6 X 50 cm^ )
light petroleuB 
and dried at
Slnilarly, 3-hydroxy-2-nethylphenol (24.80 g, 200 nmol) 
gave sodium 5-hydroxy-6-methyl-l,2-benzo<iuinone
2~oxlmate monohydrate (32.85 g, 85%) and
3-hydroxy-5-Biethylphenol (24.80 g, 200 smol) gave sodium 
5-hydroxy-3~methyl- 1,2-benzoquinone 2-oximate dihydrate 
(38.40 g 91%). (See Table 5.1 for elemental analysis).
5.4.2 Reaction s£ 3-hvdroxvphenol8 H  ssl gqvilv) with 
awvl nitrite and sodium ethoxlde 12 BSJL oauiv) at ^  °Q
Sodium (3.45 g, 150 mmol) was dissolved in dry ethanol 
(150 cm^ ) and the solution was cooled to -10 *C. To this 
solution 3-hydroxyphenol (8.25 g, 75 mmol), was added, 
followed by portlonwlse addition of amyl nitrite 
(9.65 g, 82 mmol) over a period of 1 h. The reaction 
mixture was allowed to reach 20 °C over a period of 2 h 
and then filtered to give orange disodium 
5-hydroxy-l,2-benzoquinone 2-oximate hemihydrate 
(11.97 g, 83%) which was washed with ice cold water 
(20 cm’), ethanol (20 cm’), light petroleum
(b.p. 30 - 40 C) 
0.1 mm/50 *C.
(6 X 50 cm ) and dried at
Similarly, 3-hydroxy-2-methylphenol (9.30 g, 75 mmol)
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gav« disodiuK s-hydroxy-i-methyl-l,2-benzoquinone 
2-oximate (12.85 g, 87%) and 3-hydroxy-5-methylphenol 
(9.30 g, 75 mmol) gave disodium
5-hydroxy-3-methyl-l,2-benzoquinone 2-oximate (14.10 g, 
95%). (See Table 5.1 for elemental analysis).
5.4.3 Reaction at 3-hvdroxvDhenols il OWlVl witb
amvl nitrite and sodium hydroxide 11 B2l 
flt : J J 2  * C
Sodium hydroxide (6.00 g, 150 mmol) was dissolved In dry 
ethanol (250 cm^ ) and the solution was cooled to -10 °C. 
To this solution 3-hydroxyphenol (8.25 g, 75 mmol) was 
added, followed by portlonwlse addition of amyl nitrite 
(9.65 g, 82 mmol) over a period of 1 h. The reaction 
mixture was allowed to reach 20 C over a period of 2 h 
and then filtered to give orange sodium 
5-hydroxy-1,2-benzoguinone 2-oximate monohydrate 
(7.38 g, 55%) which was washed with Ice cold water 
(20 cm^), ethanol (20 cm’), light petroleum
(b.p. 30 - 40 *C) 
0.1 mm/50 'c.
(6 X 50 cm ) and dried at
Similarly, 3-hydroxy-2-methylphenol (9.30 g, 75 mmol) 
gave sodium 5-hydroxy-6-methyl-l, 2-benzo<juinone
2- oximate monohydrate (6.77 g, 47%) and
3- hydroxy-5-methylphenol (9.30 g, 75 mmol) gave sodium 
S-hydroxy-3-methyl- 1.2-benzoquinone 2-oximate dihydrate
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(9.60 g, 61%). (See Table 5.1 for elemental analysis).
5.4.4 Reaction fi£ 3-hvdroxvphenols H  b sI gquiv) with 
amvi nitrite and ssdlUB hydroxide 12 isl eguiyl
=lSi's.
The procedure Is similar to that described In 
Section 5.4.3 except that a greater quantity of sodium 
hydroxide (12.00 g, 300 mmol) was used. 3-Hydroxyphenol 
gave dlsodium 5-hydroxy-l,2-benzo-quinone 2-oximate 
hemihydrate (6.36 g, 44%). 3-Hydroxy-2-methylphenol gave 
disodium S-hydroxy-6-methyl-l,2-benzoquinone 2-oximate 
(8.46 g, 57%). 3-Hydroxy-5-methylphenol gave disodium 
S-hydroxy-3-methyl-l, 2-benzoquinone 2-oximate (8.57 g, 
58%). (See Table 5.1 for elemental analysis).
5.4.5 Reaction 3-hvdroxvphenols II asl eguiv) with 
amvl nitrite aod sodium ethoxlde H  osl eguivl at 22 *£
The procedure Is similar to that described In 
Section 5.4.1 except that the reaction was carried out 
at 20 *C. 3-Hydroxyphenol gave sodium
1,2,3,4-benzoqulnone 2,4-oxlmate (14.94 g, 72%). 
3-Hydroxy-5-methylphenol gave sodium
5-methyl-l,2,3,4-benzoqulnone 2,4-oxlme (17.21 g, 77%). 
3-Hydroxy-2-methylphenol gave sodium
5-hydroxy-6-methyl-l, 2-benzoquinone 2-oximate
monohydrate (31.42 g, 81%). (See Table 5.1 for elemental
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analysis).
5i4i6 Reaction &£ 3-hvdroxv-6-aethvlDhenol H  mol eouivt 
with aoyi nitrite and sodluii ethoxlde 12 mol eoulv) 
2£ *S
The procedure is similar to that described in 
Section 5.4.2 except that the reaction was carried out 
at 20 *C. The product obtained was disodium 
S-hydroxY-6-methyl-1.2-benzoquinone 2-oximate (12.35 g, 
84%). (See Table 5.1 for elemental analysis).
ijuluJ Reaction ai 3-hvdroxvDhenols U, nsi eouivl with 
asyi nitrite and sodium hydroxide n  nsi eouiv) at 22
The procedure is similar to that described in 
Section 5.4.3 except that the reaction was carried out 
at 20 *C. 3-Hydroxyphenol gave sodium
1,2,3,4-benzoqulnone 2,4-oximate (3.72 g, 48%). 
3-Hydroxy-5- methylphenol gave sodium
5-methyl-l,2,3,4-benzoqulnone 2,4-oxime (3.72 g, 44%). 
3-Hydroxy-2-methylphenol gave sodium
5-hydroxy-6-methyl-l,2-benzoquinone 2-oximate
monohydrate (7.24 g, 50%). (See Table 5.1 for elemental 
analysis.)
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514.8 ««action fiX 3-hvdroxv-6-MthvlDh«nQl H  asil igulYl 
with amvl nltrlt« and aodlu» hvdroxlda 12 aQi aaulv> 
At *£
The procedure Is slnllar to that described In 
Section 5.4.3 except that a greater quantity of sodium 
hydroxide (12.00 g, 300 mmol) was used and the reaction 
was carried out at 20 *C. The product obtained was 
disodium S-hydroxy-e-methyl-l.Z-benzoquinone 2-oximate 
(8.30 q, 56%). (See Table 5.1 for elemental analysis).
5.4.9 Reaction a£ 3-hvdroxvphenols H  fflfil fiaulYl liitb 
amvl nitrite and potassium ethoxlde H  mfil oauisti
at ^  ‘s
The procedure Is similar to that described in 
Section 5.4.2 except that sodium was replaced by 
potassium (2.93 g, 75 mmol). 3-Hydroxyphenol gave 
potassium 5-hydroxy-l,2-benzoquinone 2-oximate (10.80 g, 
81%). 3-Hydroxy-2-methylphenol gave potassium 
S-tiydroxy-6-methyl-l, 2-benzoquinone 2-oximate
monohydrate (12.07 g, 77). 3-Hydroxy-5-methylphenol gave 
potassium 5-hydroxy-3-methyl-l,2-benzoquinone 2-oximate 
(11.85 g, 83%). (See Table 5.1 for elemental analysis).
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?i4ilQ Reaction sX 3-hvdrQxvphenQle H  oai ecnilvl siiXtl 
anxl nitrite and POtaseium hydroxide H  ofil ewiv) 
at =lfl *£
The procedure is similar to that described in 
Section 5.4.2 except that sodium was replaced by 
potassium hydroxide (4.21 g, 75 mmol). 3-Hydroxyphenol 
gave potassium 5-hydroxy-l,2-benzoqulnone 2-oximate 
(7.89 g, 59%). 3-Hydroxy-2-methylphenol gave potassium 
5-hydroxy-S-mett)yl-l, 2-benzoquinone 2-oximate 
monohydrate (8.72 g, 56%). 3-Hydroxy-5-raethylphenol gave 
potassium S-hydroxy-3-methyl-l,2-benzoquinone 2-oximate 
(9.14 g, 64%). (See Table 5.1 for elemental analysis).
5.4.11 Reaction ai 3-hvdroxvphenol XI B&I eouivl with 
awvl nitrite and potassium ethoxide <2 mol equlvl 
a t  *S
The procedure is similar to that described in 
Section 5.4.2 except that sodium was replaced by 
potassium (5.87 g, 150 mmol). The product obtained was 
dlpotassium 5-hydroxy-l,2-benzoquinone 2-oximate 
(12.75 g, 79%). (See Table 5.1 for elemental analysis).
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5.4.12 Reaction s£ 3-hvdroxvphenol II nsl tmiv) yittl
amvl nitrite aod potassiun hydroxide 12 nsl gqviiy]
ai =12 *s
The procedure is sltailar to that described in 
Section 5.4.2 except that sodiuai was replaced by 
potassium hydroxide (6.00 g, 150 mmol). The product 
obtained was dlpotassium 5-hydroxy-l,2-benzoquinone
2- oximate (9.97 g, 62%). (See Table 5.1 for yield and 
elemental analysis).
5.4.13 Reaction s£ 3-hvdroxvphenol n  ssl equjv) with
amvl nitrite and sodium hydroxide (1.4 mol eouiv)
=12 °£
Sodium hydroxide (5.60 g, 140 mmol) was dissolved in dry 
ethanol (250 cm^ ) and the solution was cooled to -10 °C.
3- Hydroxyphenol (11.00 g, 100 mmol), was added to the
ethanollc sodium hydroxide. Amyl nitrite (12.87 g, 
110 mmol) was added portionwise over a period of 1 h. 
The reaction mixture was allowed to reach 20 *C over a 
period of 2 h and filtered to obtain an orange coloured 
solid. The solid was washed with ice cold water
(30 cm^), ethanol (30 cm^), light petroleum 
(b.p. 30 - 40 *C) (6 X 75 cm^ ) and dried at
0.1 mm/50 *C. (Found: C, 38.7; H, 2.3; Na, 16.8; N, 
7.4) .
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^■<■14 B^ ttCtion fi£ 5-hvdroxv-6-mathvl-l.2-benzoqulnone 
2-OXi«8 aonohvdrata with calclua hydroxide
5-Hydroxy-6-fflethyl-l,2-benzoquinona 2-oxlme monohydrate 
(2.50 g, 15 mmol) in mathanol (50 cm’) was added to a 
suspension of calcium hydroxide (0.40 g, 5 mmol) in 
water (10 cm’) . The reaction mixture was stirred at 
20 C for 48 h and filtered to obtain a mauve coloured 
solid. This solid was washed with water (2 X 25 cm’), 
methanol (25 cm’) , diethyl ether (6 X 30 cm’) and dried 
at 0.1 mm/20 C to obtain bis(S-bydroxy-6-methyl-
1,2-benzoqulnone 2-oximato)calcium(II) (1.13 g, 6H)
(Found: C, 49.0; H, 3.3: Ca, 11.5; N, 8.3. C H CaN O
M  12 2 6
requires C, 48.8; H, 3.5; Ca, 11.5, N, 8.1%); 
N.m.r. :‘h [(CDj)^S0] (80 MHz) , 6 1.61 (3H, s, CH^) , 5.99
(H, d, aromatic), 6.77 (H, d, aromatic), 20.04 p.p.m.(H, 
s, OH).
S'4tl? Bsagtion si 5-hvdroxv-3-methvl-l.2-benzoauinone 
¿r.OXiine BonohYdratO with calcium hydroxide
5-Hydroxy-3-methyl-l,2-benzoquinone 2-oxime monohydrate 
(2.50 g, 15 mmol) in methanol (50 cm’) was added to a 
suspension of calcium hydroxide (0.40 g, 5 mmol) in 
water (20 cm’) . The reaction mixture was stirred at 
20 C for 48 h and filtered to obtain an orange coloured 
solid. This solid was washed with water (2 X 25 cm’), 
methanol (25 cm’), diethyl ether (6 X 30 cm’) and dried
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at 0.1 nmi/20 *C to obtain bis(5-hydroxy-3-methyl~
1.2-benzoqulnone 2-oximato)calclum(II) (1.41 g, 76%)
(Found: C, 48.4; H, 3.3; Ca, 11.8; N, 8.2. Cj^ Hj^ CaN^ O^  
requires C, 48.8; H, 3.5; Ca, 11.5, M, 8.1%); 
N.m.r. : ( (CD^)^SO] (250 HHz) , 8 2.03 (3H, s, CH^ ) , 4.96
(H, d, aromatic), 5.85 (H, d, aromatic), 20.26 (H, s, 
OH) .
Boastipn 5-hvdroxv-1.2-ben2oaulnone 2-<?xipg
with calcium hydroxide
5-Hydroxy-l,2-benzoquinone 2-oxime (2.09 g, 15 mmol) in 
methanol (SO cm^ ) was added to a suspension of calcium 
hydroxide (0.40 g, 5 mmol) in water (20 cm^). The 
reaction mixture was stirred at 20 °C for 48 h. T.l.c. 
indicated that the reaction solution consisted of at 
least 4 components. The solvent was removed under 
reduced pressure and the residue was chromatographed on 
silica gel. However, separation of the components was 
not acheved.
5.4.17 Synthesis si. N-acetvl-5-amino-l,2-benzoauinone 
2-oxime
Bis(N-acetyl-5-amlno-l,2-benzoqulnone 2-oximato)-
nickel(II) tetrahydrate (2.00 g, 4 mmol) was dissolved 
in methanol (300 cm^). The solution was added to an ion 
exchange column (15 cm X 4.5 cm, 'Dowex' SOW - X8(H) ion
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exchange resin) and eluted with sethanol/water (4:1). 
The solvent was renoved under reduced pressure to obtain 
S-acetyl-5-amino-l, 2-benzoquinone 2-oxime (1.28 g, 87%) 
(Found:C, 53.0; H, 4.1; N, 15.4. requires C, 
53.3; H, 4.4; N, 15.6%).
5.4il8 Synthesis si aodium
1.2-benzQauinone 2-oxi«iate
M-acetvl-5-awino-
N-Acetyl-5-amino-l,2-benzoquinone 2-oxine (6.00 g, 
33 Eunol) in ethanol (100 cn^ ) was added to a solution of 
sodium ethoxide (1.90 g, 28 mmol) in ethanol (50 cm^). 
The reaction solution was stirred at 20 °C for 1 h and 
the solvent was removed under reduced pressure. The 
residue was washed with ethyl acetate (4 X 50 cm^ ) , 
diethyl ether (4 X 50 cm^ ) and dried at 0.1 mm/20 *C to 
obtain sodium N-acetyl-5-amino-l,2-benzoqulnone
2-oximate (5.43 g, 96%) (Found: C, 47.7; H, 3.3; Na, 
11.0; N, 14.0. CjH^ NaN^ Ojj requires C, 47.5; H, 3.5, Na, 
11.4, N, 13.9%).
5.4.19 Acidification si aPtali metal complexes si 
5-hvdroxv-l.2-benzoauinone mono-oximes
Glacial acetic acid (ca. 50 cm^ ) was slowly added with 
stirring to a mixture of the alkali metal complex 
(100 mmol) and crushed ice (ca. 50 g). The mixture was 
left standing for 1 h and filtered. The solid was washed
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with water (3 X 30 ce’) and dried at O.i ma/50 *C. (See 
Table 5.1 for elemental analysis).
5i4i2Q Interaction s£ 
5-hvdroxv-l.2-benzoauinone 
corresponding free ligand
sod t im or potassium
mono-oximes with their
Sodium 5-hydroxy-l,2-benzoquinone 2-oxlmate monohydrate, 
(1.79 g, 10 nmol) was digested with the corresponding 
free ligand, i.e. 3-hydroxy-l,2-benzoquinone 2-oxime 
(1.39 g, 10 mmol) in refluxing methanol (50 cm^ ) . After 
1 h the solution was cooled and the solvent was removed 
under reduced pressure. Comparitive t.l.c. of the 
residue indicated that only the starting materials were 
present. This was confirmed by extraction of the residue 
with diethyl ether. The free ligand dissolved in diethyl 
ether where as the sodium complex did not (identified by 
i.r.).
Sodium 5-hydroxy-3-nethyl-l,2-benzoquinone 2-oximate 
dihydrate, sodium 5-hydroxy-6-methyl-l,2-benzoquinone 
2-oximate monohydrate and the potassium dérivâtes of 
these compounds behaved similarly.
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5.4.21 R«actlon at 5-hvdroxv-3-aethvl-l.2-ben2oaulnone 
2-oxiaa aonohvdrate with aaMonlua iron(III sulphate 
hexahvdrate
AaioonluD iron(II) sulphate hexahydrate (9.80 g, 25 nDol) 
in water (70 cm^ ) was added to a solution of 
5-hydroxy-3-Bethyl-l, 2-benzoquinone 2-oxiine monohydrate 
(8.55 g, 50 mmol) In methanol (150 cm^ ) . The reaction 
mixture was stirred at 20 °C for 48 h and filtered to 
give a dark green solid. This solid was washed with 
water (75 cm^ ) , methanol (50 cm^ ) , ethyl acetate 
(100 cm’), and dried at O.lmm/60 *C to give 
bis(S-hydroxy-S-methyl-l,2-benzoquinone 2-oxi- 
mato)iron(II) dihydrate (7.62 g, 77%) (Found: C, 42.3: 
H, 3.9; Fe, 13.9; N, 7.1. C^ H^j^ FeN^ O^  requires C, 42.4; 
H, 4.0; Fe, 14.1; N, 7.1%).
5.4.22 Reaction ai 5-hvdroxv-l.2-benzoauinone ?-Pxlffl£ 
with ammonium irgtUII) sulphate hexahydrate
Ammonium Iron(II) sulphate hexahydrate (19.60 g, 
50 mmol) In water (150 cm’) was added to a solution of 
5-hydroxy-l,2-benzoqulnone 2-oxlme (13.90 g, 100 mmol) 
In methanol (400 cm’). The reaction mixture was stirred 
at 20 *C for 48 h and filtered to obtain a dark green 
solid. This solid was washed with water (150 cm’), 
methanol (100 cm’), and finally extracted (Soxhlet) with 
ethyl acetate. The residue was dried at O.lmm/60 *C to
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give bis(S-hydroxy-l,2-benzoguinone 2-oximato)iron(II) 
trlhydrate (11.62 g, 60%) (Found: C, 37.1; H, 3.4; Fe, 
14.1; N, 7.0. requires C, 37.3; H, 3.6; Fe,
14.5; N, 7.3%).
5.4.23 Reaction of 5-hvdroxv-6-methvl-l.2-benzoaulnone 
Zr.gxiffiO monohvdrate with amaionluM Iron (II) sulphate
Amnonlum Iron(II) sulphate hexahydrate (9.80 g, 25 mmol) 
In water (70 cm^ ) was added to a solution of 
5-hydroxy-6-methyl-l,2-benzoqulnone 2-oxlme monohydrate 
(8.55 g, 50 mmol)ln methanol (150 cm^ ) . The reaction 
mixture was stirred at 20 *C for 48 h and filtered to 
obtain a dark green solid. This solid was washed with 
water (75 cm^ ) , methanol (50 cm^), and finally extracted 
(Soxhlet) with ethyl acetate. The residue was dried at 
O.lmm/60 *C to give bis(S-hydroxy-6-methyl-
1,2-benzoquinone 2-oximato)iron(II) dihydrate (5.4 g, 
55%) (Found: C, 42.7; H, 3.6; Fe, 13.9;, N, 7.0. 
Cj^Hj^ FeN^ Oa requires C, 42.4; H, 4.0; Fe, 14.0; N, 
7.1%).
5.4.24 Interaction el bls(3-hvdroxv-1.2-aulnone
mono-oxlmato)Iron(ID hydrates with pyridine
The bls(5-hydroxy-l,2-benzoqulnone mono-
oxlmato) Iron(II) hydrate (2.00 g) was refluxed In
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pyrldln« for 2 h and filtered hot. The residue was 
washed with diethyl ether (5 X 50 cn^ ) and dried at 
0.1 nn/20 *C. (See Table 5.2 for yields and elemental 
analysis).
5t4t25 Rftagtion a£ 3-hvdroxvphenol with sodium 
nltrlte/acetlc acid in ^  presence ammonium Iron(in 
sulphate hexahvdrate
Sodium nitrite (25.00 g) in water (50 cm^ ) was added 
dropwlse with stirring to a solution of 3-hydroxyphenol 
(11.01 g, 100 mmol), ammonium iron(II) sulphate 
hexahydrate (19.61 g, 50 mmol), acetic acid (45 cm^ ) and 
sodium acetate trlhydrate (45.00 g) in ethanol/water 
(1:1) (600 cm^ ) at 0 °C. The reaction mixture was 
stirred at 20 'c for 24 h and then filtered to obtain a 
black solid. The solid was washed with water 
(3 X 100 cm^), ethanol (3 X 50 cm^ ) , diethyl ether 
(2 X 50 cm^ ) and dried at 0.1 mm/50 *C to give a black 
solid (solid SI) (21.20 g) (Found: C, 27.9; H, 2.4; Fe, 
14.5; Na, 3.9; N, 11.2t). (See Table 5.3 for Mossbauer 
and t.g.a. results).
5.t.4j.2$ Interaction si solid SI with pyridine
The solid SI (5.00 g) was digested in pyridine (150 cm^ ) 
at 50 *C for 2 h and filtered hot. The solid was washed 
with ethanol (50 cm’) , light petroleum (b.p. 30 - 40 °C)
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(6 X 75 c»’). Th* résidu* was dried at 0.1 rai/20 *C to 
obtain a solid (solid S2) (4.68 g) (Found: C, 33.0; H,
2.6; Fe, 12.4; Na, 3.3; N, 11.9%). (See Table 5.3 for 
Hôssbauer and t.g.a. results).
5.4.27 Reaction si 3-hvdroxv-5-aethvlPhenQl ffionPhYdrate 
with sodium nitrite/acetic acid in thS PfOggnOfi 
ammonium ironfll) g^lphatfi hgxatlYdratS
Sodium nitrite (25.00 g) in water (50 cm^ ) was added 
dropwise with stirring to a solution of 
3-hydroxy-5-methylphenol monohydrate (14.20 g,
100 nmol), ammonium iron(II) sulphate hexahydrate 
(19.61 g, 50 mmol), acetic acid (45 cm^ ) and sodium 
acetate trihydrate (45.00 g) in ethanol/water (1:1) 
(500 cm^ ) at 0 'c. The reaction mixture was stirred at 
20 'c for 48 h and then filtered to give a solid. The 
solid was washed with water (3 X 100 cm^ ) , ethanol 
(3 X 50 cm’), diethyl ether (2 X 50 cm’) and dried at 
0.1 mm/50 *C to give a black solid (solid S3) (20.40 g)
(Found: C, 31.3; H, 2.8; Fe, 12.2; Na, 2.4; N, 11.2%). 
(See Table 5.3 for Mossbauer and t.g.a. results).
5.4.28 Interaction si solid £1 with PYCiding
The solid S3 (5.00 g) was digested in pyridine (150 cm’) 
at 50 *C for 2 h and filtered hot. The solid was washed 
with ethanol (50 cm’), light petroleum (b.p. 30 - 40 °C)
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(6 X 75 ctT). The residue was dried at 20 C/0.1 an to 
give a blacX solid (solid S4) (4.60 g) (Found: C, 37.7; 
H, 2.9; Fe, 10.3; Na, 2.2; N, 11.9%). (See Table 5.3 for 
Mossbauer and t.g.a. results).
5.4.29 Reaction s£ 3-hvdroxv-2-nethvlphenol SQijium
nitrite/acetic acid In ^  presence al aamoniun iron(II) 
awXBtlflte hexahvdrate
Sodium nitrite (25.00 g, 36 mmol) in water (50 cm^ ) was
added dropwlse with stirring to a solution of
3-hydroxy-2-methylphenol monohydrate (12.40 g,
100 mmol), ammonium Iron(II) sulphate hexahydrate 
(19.61 g, 50 nmol) , acetic acid. (45 cm^ ) and sodium 
acetate (26.00 g) in ethanol/water (1:1) (400 cm^ ) at
0 *C. The reaction mixture was stirred at 20 'c for 48 h 
and then filtered to obtain a solid. The solid was
washed with water (3 X 100 ca^), and methanol
(3 X 50 ca^ ) followed by extraction (Soxhlet) with ethyl 
acetate. The residue was dried at 0.1 nm/50 *C to obtain 
a blac)c solid (solid S5) (11.60 g) (Found: C, 44.8; H,
3.7; Fe, 11.3; Na, 2.55; N, 8.0%). (See Table 5.3 for 
Kossbauer and t.g.a. results).
5.4.30 Interaction solid SI with pyridin?
The solid S5 (1.20 g) was digested in pyridine (50 cm^ ) 
at 50 °C for 2 h and filtered hot. The solid was washed
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with ethanol (50 cn^) , ethyl acetate (50 cn^), light 
petroleum (b.p. 30 - 40 *C) (6 X 50 cm^ ) . The residue
was dried at 20 *C/0.1 mm to obtain solid (solid S6) 
(1.15 g) (Found: C, 47.5; H, 3.7; Fe, 9.3; Na, 2.1; N, 
9.3%). (See Table 5.3 for Mossbauer and t.g.a. results).
5.4.31 Reaction a£ N-acetvl-3-aminophenol with 
nitrite/acetic acid in ills presence s£ ammonium iron(II) 
sulphate hexahvdrate
Sodium nitrite (14.00 g, 203 mmol) in water (60 cm^ ) was 
added dropwise with stirring to a solution of ammonium 
iron(II) sulphate hexahydrate (29.40 g, 75 mmol), 
N-acetyl-3-aminophenol (22.65 g, 150 mmol) acetic acid 
(45 cm^ ) and sodium acetate in ethanol/water (1:1) 
(600 cm’) at 0 *C. The mixture was set aside at 20 "c 
for 72 h and then filtered to obtain a dark green solid. 
A portion (2.50 g) of this solid was chromatographed on 
silica gel. Elution with ethyl acetate gave 
N-acetyl-3-amino-l,4-benzoqulnone 4-oxime (0.30 g) m.p. 
187 - 190 *C (decomp.) (Found: C, 53.3; H, 4.5; N, 15.6. 
CgHsN^O^ requires C, 53.3, H, 4.4; N, 15.6%); m/z 180 
(M*) . Elution with methanol gave sodium tris(N-acetyl- 
S-amino-1,2-benzoquinone 2-oximato)ferrate(II ) tetra- 
hydrate (1.36 g) (Found: C, 41.7, H, 4.3;, Fe, 8.2; Na, 
3.1; N, 12.0. C^^H^FeNaN^Ojj requires C, 41.9; H, 4.2; 
Fe, 8.1; Na, 3.3; N, 12.2%). Pyridine was then added to 
the chromatographey column. Elution with methanol after
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Details of The Crystal Structure of 
3-Hydroxy-2-aethyl-l,4-benzoqulnone 4-o x1m  eonohydrate
Table 1 Atonic coordinates and paraneter?
£S£ £lia non-hvdroaen atoms In 3-Hydr0XY-2-methYl- 
1.4-benzoauinone 4-oxime monohvdrate
Atom X y z u• q
C(l) 0.4151(13) 0.2417(3) 0.1996(3) 0.0371(16)
C(2) 0.3384(12) 0.3310(3) 0.2500(3) 0.0359(15)
C(3) 0.1796(12) 0.3307(3) 0.3318(3) 0.0370(16)
C(4) 0.0755(15) 0.2378(3) 0.3688(3) 0.0400(17)
C(5) 0.1525(15) 0.1486(4) 0.3182(4) 0.0463(19)
C(6) 0.3135(14) 0.1505(3) 0.2388(3) 0.0419(18)
C(7) 0.1000(17) 0.4209(4) 0.3855(4) 0.0474(20)
N 0.5747(11) 0.2536(3) 0.1232(3) 0.0428(15)
0(1) 0.6475(10) 0.1687(3) 0.0784(2) 0.0571(14)
0(2) 0.4374(9) 0.4157(2) 0.2130(2) 0.0504(13)
0(3) -0.0746(10) 0.2317(3) 0.4444(2) 0.0547(14)
0(W) 0.7510(11) 0.0561(3) 0.5369(3) 0.0783(17)
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Tabi* 2 Atoilc gflgrdinatgg and thermal parameters 
Xfi£ thfi todri?gen atoms in 3-Hvdroxv-2-methvl- 
1.4-benz9guin9ne 4-oxlme monohvdrate
Atom X y z U
H(01) 0.733(15) 0.199(5) 0.023(4) 0.087(21)
H(02) 0.521(17) 0.410(5) 0.152(5) 0.111(25)
H1(C7) 0.190(14) 0.413(4) 0.454(4) 0.070(17)
H2(C7) 0.159(17) 0.475(5) 0.344(5) 0.099(22)
H3(C7) -0.123(23) 0.431(7) 0.400(6) 0.158(37)
H(C5) 0.084(12) 0.096(4) 0.342(3) 0.049(15)
H(C6) 0.351(11) 0.093(3) 0.206(3) 0.042(13)
Table 3 Bond Length» lAl iar 2-Methvl-3-hvdroxv- 
li4-bengOOTlnone 4-oxime monohvdrate
C(l) - C(2) 1.458(6) C(3) - C(7) 1.495(7)
C(2) - C(3) 1.340(6) C(4) - 0(3) 1.247(5)
C(3) - C(4) 1.445(6) C(5) - H(C5) 0.84(5)
C(4) - C(5) 1.458(7) C(6) - H(C6) 0.93(5)
C(5) - C(6) 1.314(7) C(7) - H1(C7) 1.03(6)
C(6) - C(l) 1.434(6) C(7) - H2(C7) 0.98(6)
C(l) - N 1.284(6) C(7) - H3(C7) 0.92(9)
N - 0(1) 1.364(6) 0(1) - H(01) 0.96(6)
C(2) - 0(2) 1.341(5) 0(2) - H(02) 0.94(7)
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Tabi« 4 Band Anales ili la r 2-M«thvi-3-hvdroxv-
1.4-benzoaulnon« 4-OXlm« »onohvdrat«
C(6) - C(l) - C(2) 118.6(4)
C(6) - C(l) - N 126.3(4)
C(2) - C(1) - N 115.1(4)
C(l) - C(2) - C(3) 122.4(4)
C(l) - C(2) - 0(2) 118.0(4)
C(3) - C(2) - 0(2) 119.6(4)
C{2) - C(3) - C(4) 117.8(4)
C(2) - C(3) - C(7) 123.6(4)
C(4) - C(3) - C(7) 118.6(4)
C(3) - C(4) - C(5) 119.8(4)
C(3) - C(4) - 0(3) 121.5(4)
C{5) - C(4) - 0(3) 118.8(4)
C(4) - C(5) - C(6) 121.5(5)
C(5) - C(6) - C(l) 120.0(5)
C(l) - N - 0(1) 113.8(4)
C(4) - C(5) - H(C5) 116(3)
C(6) - C(5) - H(C5) 122(3)
C(5) - C(6) - H(C6) 120(3)
C(l) - C(6) - H(C6) 120(3)
C(3) - C(7) - H1(C7) 109(3)
C(3) - C(7) - H2(C7) 105(4)
C(3) - C(7) - H3(C7) 117(6)
H1(C7) - C(7) - H2(C7) 125(5)
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Table 4 cont.
H1(C7) - C(7) - H3(C7) 96(6)
H2(C7) - C(7) - H3(C7) 105(7)
N - 0(1) - H(01) 96(4)
C(2) - 0(2) - H(02) 114(4)
Table 5 Less than the Sum
£b£ Corresponding ^  Qsr Waals Radii
H 0(3)" 2.942(5) 0(W) ••• O(W)'' 2.687(6)
N 0(W)'" 2.981(6) 0(W) • •• O(W)''' 2.731(6)
0(1) ••• 0(3)" 2.616(5) C(4) ••• H(Ol)’'" 2.75(6)
0(2) ••• 0(W)"' 2.856(5) 0(3) ••• H(Ol)’'" 1.67(6)
0(3) ••• 0(W)' 2.844(6) 0(W) ••• H(02)" 1.95(7)
SysMtry Cod«:
I: -!♦*, y, *
II: l*x, 1/2-y, • \ /2 * z
III: K, l/2-y, -l/2^a
IV: K, 1/2-y. l/2^x
V: 1-«, -y, l-x
VI: 2-x, -y, l-x
VII: -l*x, 1/2-y, l/2*x
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Table 7 Observed aod Calculated Structure Factors
H K 1 M O I F (C ) H K L F 40) F C C I H K L F IO I M C I
1 0 0 16«4 16*6 1 13 0 6 .6 6 .0 -2 6 1 i . i 6 .1
2 0 04 2 .3 1.7 2 13 0* 2 .8 2 .3 -1 6 1 14.( 15.2
3 0 04 0*7 2 .0 0 14 0 4 .2 3*5 0 6 1 12.1 11*5
4 0 0 7.7 9 .9 1 14 0 5.4 6 .4 1 6 1 1*.} 16*0
1 1 0 31.9 31*7 2 14 04 0 .8 1.8 2 6 1 13.1 12.9
2 1 0 7.7 a*2 1 15 0 9*9 8 .8 3 6 14 2.« 0*9
3 i 0 3 .6 3 .0 0 16 04 2 .0 3 .7 4 6 14 2 .4 0 .3
4 1 04 o .a 0.1 -4 1 14 0*8 0 .8 «4 7 14 2 .1 1 .5
i 2 0 3 .4 3*1 -3 1 1 5 .8 6 .1 -3 7 1 5.1 5 .5
2 2 0 16.0 15.5 -2 1 1 10.8 10.6 -2 7 14 1.4 2 .5
3 2 c 4 .5 5 .4 -1 1 1 3.8 2 .6 -1 7 1 4 .5 6*8
4 2 0 4.2 5 .9 1 1 1 14.1 13*9 0 7 1 22 .1 23.5
1 3 0 14.0 15*7 2 1 1 3*0 2.0 1 7 1 9 .1 9*2
2 3 04 1.4 0 .6 3 1 1 8*0 7.7 2 7 1 3 .2 3 .2
3 3 0 12.7 12*1 4 1 !• 1.9 3 .9 3 7 14 0 .7 0 .1
4 3 04 2 .3 1*2 -4 2 |4 1*6 0.4 4 7 14 0.( 1*0
0 4 04 0 .6 0 . 4 -*3 2 1 7 .6 7.9 - 4 8 14 0 .1 1 .6
1 4 0 10.2 10.3 -2 2 1 25*3 24*2 -3 8 14 2 .6 3 .3
2 4 0 26.0 23*3 -1 2 1 3*5 4 .9 -2 8 14 2 .7 3 .0
3 4 04 0 .7 0 .3 0 2 1 18.4 18.0 -1 8 1 5 .2 6 .8
4 4 04 O .a 0 .0 1 2 1 22*1 20 .8 0 8 1 12.2 12.6
1 5 0 34.0 34 .8 2 2 1 7.6 7 .0 1 8 1 16.4 17.8
2 5 0 9.1 7 .8 3 2 14 3.1 2 .7 2 8 14 2 .2 1.1
3 5 0 9 .3 9 .1 4 2 14 0*8 0.1 3 8 1 5.1 6 .1
4 5 04 O.S 0.6 -4 3 14 0 .8 0*5 4 8 14 2 .3 0 .8
0 e 0 33.7 33.9 -3 3 1 4 .9 4 .5 -3 9 14 l .( 1.6
1 6 04 1*5 0*9 -2 3 1 6*0 6*6 “ 2 9 1 10.7 11.2
2 6 0 35*5 33.6 -1 3 1 28*9 3C.2 -1 9 1 3 .0 6 .1
3 6 0 6 .9 6 .4 0 3 1 26 .7 26*9 0 9 1 15.0 16.9
4 6 04 2 .6 0 .2 1 3 1 11.9 12.8 1 9 1 13.0 13*3
t 7 04 2 .2 2 .4 2 3 1 18.9 20 .0 2 9 14 0 .7 1 .2
2 7 0 7.1 6 .7 3 3 14 2.1 1 .9 3 9 1 4 .4 6 .5
3 7 0 3 .7 3.3 4 3 14 1.8 0 .7 -3 10 14 3 .5 6*0
4 7 04 2 .0 1.1 - 4 4 14 2*3 1.9 -2 10 1 10.1 10.7
0 a 0 5.1 4 .6 -3 4 1 3 .8 2*5 -1 10 14 2 .3 0 .1
1 8 04 1*7 3.1 -2 4 1 5.6 5 .6 0 10 1 26 .1 26.1
2 a 0 14*9 14.6 “ 1 4 1 21.4 22.4 1 10 14 2 .6 1.7
3 a 04 1.9 0 .7 0 4 1 46 .6 46 .9 2 10 1 5 .2 6*1
4 a 04 1.7 0 .7 1 4 1 34.0 35.5 3 10 14 O .a 0 .6
1 9 04 2 .4 0 *6 2 4 1 13.9 13.3 -3 11 14 2 .4 6 .7
2 9 04 2 .5 2*9 3 4 14 2 .4 0*6 -2 11 14 i . t 3*3
3 9 0 4 .8 5 .2 4 4 14 3*1 3.0 -1 11 1 7 .3 8 .6
0 10 0 39.3 30.1 - 4 5 14 2 .2 1*0 0 11 1 2 2 .0 20*7
1 10 04 0*7 1.3 -3 5 1 7.3 7.1 1 11 1 26 .5 25 .2
2 10 0 5 .0 5 .6 -2 5 1 11*0 10.3 2 11 1 4 .5 6*6
3 10 C4 0 .8 1.7 -1 5 1 28.3 29.6 3 11 14 3 .0 6 .6
1 11 0 9.1 9*2 0 5 14 1.5 1*8 -3 12 14 0 .0 0 .2
2 11 0 4 .2 4 .5 1 5 1 13*9 14.4 "2 12 14 1.4 0*3
3 11 04 3.2 3.1 2 5 1 7 .0 5*5 •1 12 14 2 .4 2 .8
0 12 0 39.3 38.8 3 5 1 6 .9 6 .6 0 12 1 14.5 13.7
1 12 0 10.4 9 .9 4 5 14 0 .8 1.9 1 12 1 7 .5 6*6
2 12 0 4 .6 3*9 - 4 6 14 0 .8 0*9 2 12 14 1.6 2 .3
3 12 04 0 .9 0 .2 -3 6 |4 0 .7 0 .3 3 12 14 2 .2 1.1
*>:Unoba6rv*d r«n«cttons
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Table 7 (cont.)
H K L MO) F(C) H K L FIO) FICI H K L FIOI FIO
1 3 3 2 3 . 9 2 5 . 1 2 9 34 2 . 6 2 . 9 3 1 4* 3 .1 2 . 7
2 3 3 4 * 2 4 . 3 3 9 34 2 * 8 2 . 7 4 1 4 6 0 . 9 1 .5
3 3 34 let 0 . 2 - 3 10 34 2 . 9 4 . 4 - 4 2 4 6 0 . 8 1 .1
4 3 34 0 * 8 0 . 2 - 2 10 3 7 . 7 8. 6 - 3 2 4 5 . 6 4 . 8
- 4 3 6 * 7 8 . 1 - 1 10 3 1 7 .7 1 8 .7 - 2 2 4 2 0 . 3 1 9 .1
- 3 4 34 3 .1 2 . 2 0 10 3 7 . 2 7 . 0 - 1 2 4 2 8 . 8 2 7 .6
- 2 4 3 2 1 . 8 2 1 . 0 1 10 3 2 6 * 0 2 6 . 1 0 2 4 2 6 . 2 2 6 .2
- 1 4 3 3 5 . 7 3 5 . 9 2 10 3 1 3 . 6 1 2 * 6 1 2 4 6 * 4 5 .9
0 4 3 4 2 . 9 4 3 * 7 3 10 34 1 .9 3 . 1 2 2 4 2 9 * 9 2 6 * 3
1 4 3 3 . 0 3 . 9 - 3 11 34 3 .0 4 * 7 3 2 4 4 * 6 4 .2
2 4 34 U 8 1 .1 - 2 11 34 2 . 1 C. 8 4 2 4 6 3 . 6 1*8
3 4 3 9 . 3 9 . 2 - 1 11 3 7 .0 6 . 8 - 4 3 4 4 . 2 4 . 7
4 4 34 U 8 1 .4 0 11 3 3 . 5 2 . 8 - 3 3 4 6 0 . 7 2*0
- 4 5 34 0 . 9 2 * 5 1 11 3 1 0 .5 1 1 * 0 - 2 3 4 8 . 2 7 .3
- 3 5 34 1 .7 1 .0 2 11 3 5 . 9 5 . 4 - 1 3 4 2 9 . 6 3 0 .4
- 2 5 3 3*1 4 . 3 3 11 34 0 . 8 2 * 2 0 3 4 2 0 * 5 2 1*2
- 1 5 34 0 * 6 1 .2 - 3 12 34 2 .1 0 . 8 1 3 4 9 . 5 1 0 .1
0 5 3 1 5 . 0 1 4 . 7 - 2 12 34 1 . 6 2 * 2 2 3 4 6 1 .7 1 .0
1 5 3 1 2 * 2 1 1 .4 - 1 12 34 2 . 7 1 .6 3 3 4 6 0 . 7 0*2
2 5 3 9 . 0 8 . 6 0 12 3 6 . 9 6 . 9 4 3 4 6 0 . 8 2 . 4
3 5 3 3 . 9 4 . 8 1 12 3 1 3 .6 1 3 . 5 - 4 4 4 4 . 8 7 .1
4 5 34 1 .8 2 * 4 2 12 3 1 1 .2 1 1 .2 - 3 4 46 0 . 7 0 .5
- 4 6 34 3 .1 4 * 4 3 12 34 1 .6 0 . 5 - 2 4 4 5 . 7 5 .1
- 3 6 34 3 . 3 4 . 7 - 2 13 34 2 . 7 1*8 - 1 4 4 1 6 . 8 1 8 .0
- 2 4 3 3 . 0 2 . 8 - 1 13 3 5 .2 6 . 6 0 4 4 2 6 . 9 2 7 .5
- 1 6 3 5 . 9 5 .1 0 13 34 1 .9 1 .8 1 4 4 1 4 . 0 1 3 .7
0 6 3 8 . 7 9 . 0 1 13 3 4 * 4 4 . 3 2 4 4 4 . 4 4 . 4
1 6 3 1 0 . 4 1 0 * 4 2 13 34 2 . 6 3 . 0 3 4 4 6 * 6 5 .5
2 6 34 2 . 8 1 . 9 - 2 14 34 0 . 8 1*2 4 4 4 6 0 . 8 4 .1
3 6 34 0 . 7 1 .4 - 1 14 34 2 . 6 1*6 - 4 5 4 1 2 . 4 1 7 .5
4 6 34 0 . 9 2 . 0 0 14 3 9 . 8 8 . 6 - 3 5 4 6 1 *8 1*3
- 4 7 34 2 . 6 0 . 3 1 14 3 4 . 8 2 * 9 - 2 5 4 4 . 4 4 . 9
- 3 7 3 3 . 7 1 .6 2 14 34 0 . 8 2 * 4 - 1 5 4 2 1 . 0 2 1 .3
- 2 7 3 7 .6 7 .9 - 1 15 34 1 .9 C. 5 0 5 4 4 8 . 1 4 7 .3
- 1 7 34 2 . 1 1 .0 0 15 34 2 . 7 1 .8 1 5 4 1 9 . 1 1 9 .8
0 7 3 7 . 6 8 .1 1 15 34 1*8 0 . 4 2 5 4 1 0 * 2 1 0 .2
1 7 3 2 1 . 6 2 2 . 1 0 16 3 8 . 7 7 . 6 3 5 4 4 . 7 5 .6
2 7 3 1 3* 5 1 3 . 2 - 4 0 4 4 . 9 4 . 9 4 5 4 6 0 . 9 5 . 5
3 7 3 4 . 4 3 . 5 - 3 0 4 1 0 * 2 9 *1 - 4 6 4 8 . 4 1 2 .7
4 7 34 1 .7 2 . 1 - 2 0 4 3 8 . 4 3 2 .1 - 3 6 4 8 . 9 8 . 3
- 4 8 34 0 . 9 2 . 1 - 1 0 4 5 5 . 5 5 1 . 6 - 2 6 4 4 . 6 5 .2
- 3 8 3 4 . 1 3 . 9 Ü 0 4 4 . 2 5 . 2 - 1 6 4 1 6 . 3 1 5 .7
- 2 8 3 3 .4 3 .9 1 0 4 1 4 .4 1 4 . 2 0 6 4 1 9 . 2 1 7 .7
- 1 8 3 4 . 7 4 . 7 2 0 4 6 0 * 4 5 5 . 7 1 6 4 5 . 9 6 .6
0 6 3 5 . 9 5 . 4 3 0 4 1 2 .0 1 1 . 8 2 6 4 6 1 . 9 1 .1
1 8 3 8 . 1 8 . 5 4 0 44 0 . 8 1 . 0 3 6 4 4 * 2 4 . 4
2 8 34 2 . 0 4 . 3 - 4 1 4 4 1 . 8 1 . 9 4 6 4 6 1 * 9 4*1
3 8 34 2 . 1 1 .6 - 3 1 4 6 . 4 5 .4 - 4 7 4 8 . 1 1 1 .7
- 3 9 34 1 . 9 1 .6 - 2 1 4 2 2 . 1 1 6 . 6 - 3 7 4 6 2 . 1 1 .9
- 2 9 3 8 . 5 9 . 5 - 1 1 4 1C. 9 1 2 . 0 - 2 7 4 4 . 7 4 .6
- 1 9 34 1 . 3 0 . 6 0 1 4 4 1 .2 1 *6 - 1 7 4 7 . 3 7 .1
0 9 3 8 . 6 9 * 4 1 1 4 1 7 .2 1 9 . 4 0 7 4 4 9 . 2 4 6 .4
1 9 3 3 . 5 3 . 2 2 1 4 6 1 . 6 5 5 . 4 1 7 4 4 . 1 4 .3
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Tab le 7 (cont.)
H K L fiOi FICl H K L FIO) F(CI H K L FIQI FIG)
2 7 4 3 . 9 3 .0 -1 1 5 16* 2 1 6 .4 - 2 7 56 1 .9 1 .7
3 7 4» 2 .1 1 .6 0 1 5 4 0 . 3 4 0 .1 - 1 7 5 3*4 4 . 1
M 7 4« 3 .2 5 . 2 1 1 5 3 . 8 3 .9 0 7 5 3 *9 4 . 2
• 3 6 4« 0 . 7 0 . 6 2 1 5 1 0 .8 lO.O 1 7 5 3 *5 3 . 3
8 44 1 . 6 0 .0 3 1 5 6 . 4 6 . 2 2 7 56 1 .5 0*2
- 1 8 4 2 0 . 0 2 0 . 9 4 1 56 0 * 8 1 .6 3 7 56 0 . 8 2 . 5
0 8 4 1 3 .2 1 4 .3 - 4 2 5* 1 . 8 2 . 9 - 3 8 5 3 . 9 2 . 5
1 8 44 0 . 6 1*6 - 3 2 5 1 0 .4 9 . 8 - 2 8 5 4 . 0 4 .1
2 8 4 5 . 6 5 . 0 - 2 2 5 1 0 .1 1C. 5 - 1 8 5 1 7 .7 1 8 .8
3 8 44 2 . 0 2 . 0 - 1 2 5 3 . 6 2 . 4 0 8 56 2 . 4 1*6
- 3 9 4 5 . 2 4 . 5 0 2 5 2 . 9 3 .3 1 8 56 3 .1 2 . 4
- 2 9 4 3 .6 4 .2 1 2 5 8 . 8 8 .1 2 6 5 6 . 3 6 . 7
- 1 9 4 7 .1 7 .4 2 2 5 9 . 6 9 . 0 3 8 56 0 . 8 0 .1
0 9 4 3 .8 3*9 3 2 5 5 . 4 5 .8 - 3 9 56 0 . 8 1 .5
1 9 4 3 . 7 4 .1 4 2 5* 0 . 8 1 .4 - 2 9 5 1 0 .8 ll .O
2 9 4 3 . 8 3 .1 - 4 3 5« 3 . 2 1 .6 - 1 9 5 9 . 2 1 0 .1
3 9 44 2 . 3 2 . 2 - 3 3 5 7 .1 7 .0 0 9 5 1 4 .4 1 4 .9
- 3 10 44 3 .6 6 . 8 - 2 3 5 5 .1 4 . 4 1 9 56 3 .2 4 . 4
- 2 10 44 0 . 7 1 .8 -1 3 5 1 1 . 9 1 2. 7 2 9 5 12* 1 1 1 .8
- 1 10 44 0 . 7 1 .9 0 3 5* 2 . 3 2 * 6 3 9 5 4. 1 2 .1
0 10 44 1 .8 2 . 2 1 3 5 1 6 . 4 1 7 . 6 - 3 10 56 2 . 6 2 . 6
1 10 44 2 . 9 1 .2 2 3 5 4 . 8 5 . 3 - 2 10 56 1 .5 1 .4
2 10 4 1 5 . 6 1 5 .4 3 3 5 4 . 6 3 .4 - 1 10 56 1 . 5 0 .7
3 10 44 3 . 4 2 .9 4 3 5* 0 . 8 3 . 9 0 10 56 2 . 7 3 .2
- 3 11 44 2 . 2 3 .4 - 4 4 5» 2 . 2 2 . 4 1 10 5 4 . 3 4*4
- 2 11 4 8 . 8 9 . 6 - 3 4 5 1 0 .3 9 . 8 2 10 56 0 . 7 1 .4
- 1 11 44 1 .9 C.4 - 2 4 5* 0 . 6 0 . 1 3 10 5 6 . 0 7 .4
0 11 4 5 . 0 5 .1 -1 4 5 1 7 . 0 1 7 .7 - 3 11 56 0 . 8 2 .1
1 11 4 9 . 2 9 .2 0 4 5 3 3 . 0 3 2 . 9 - 2 11 56 3 . 9 5 .6
2 11 4 2 o.J 2 0 .1 1 4 5 8 . 4 8 .4 - 1 11 56 2 . 0 3 .9
3 11 4 4 0 . 8 1 .4 2 4 5 1 1 .2 1 C. 8 0 11 5 1 1 .4 1 1 .4
- 3 12 44 2 . 2 l.O 3 4 5 3 . 7 2 . 9 1 11 5 8. 7 8 .6
- 2 12 4 8 .4 9 .1 4 4 5# 0 . 8 1. 3 2 11 5 1 6* 5 1 6 .7
12 4 8 . 7 8 .9 - 4 5 5 5 . 7 6 . 3 3 11 56 0 . 9 4 *5
0 12 4 6 . 2 5 .4 - 3 5 5 1 0 .4 9 . 6 - 2 12 5 7 .1 6 . 5
1 12 4 5 . 7 4 . 9 -2 5 5 8 . 5 8 . 4 - 1 12 56 2 . 0 0 . 3
2 12 4 1 0 .7 1 0 .4 - 1 5 5 9 .1 9 . 7 0 12 56 1 .1 0 . 8
- 2 13 4 6 . 6 7 .0 0 5 5 2 5 . 2 2 4 . 9 1 12 56 1 . 6 1 .6
- 1 13 44 2 . 0 2 .3 1 5 5 7 . 9 6 . 4 2 12 56 2 * 2 2 .7
0 13 4 3 . 0 2 . i 2 5 5 4 . 9 4 . 9 - 2 13 56 2 . 3 2 . 7
1 13 4 6 . 7 6 . 9 3 5 5» 2 . 4 1 . 0 - 1 13 5 4 . 0 3 .0
2 13 4 1 0 .9 1 0 .6 4 5 5* 2 . 4 2 . 9 0 13 56 2 . 5 3 .1
- 2 1^ 44 2 .1 1 .4 - 4 6 54 0 . 9 C. 2 1 13 56 3 . 3 0 .6
- 1 14 44 l.B 2 .1 - 3 6 5 3 .9 3 . 6 2 13 56 3 . 8 1 .7
0 14 4 5 . 6 4 . 9 - 2 6 5 4 . 9 6 . 0 - 2 14 56 0 * 8 0 . 5
1 14 4 4 .1 4 .1 - 1 6 5 3 . 3 2 . 1 - 1 14 56 0 . 7 1 .3
2 14 44 0 . 8 2 .1 J 6 5* l . l 1 . 8 0 14 5 5 . 3 4 . 3
- i IS 44 1 .9 C.9 1 6 5 1 1 . 6 1 1 . 9 1 14 56 2 . 1 2 .3
0 15 4 3 .8 2 . 9 2 6 5 7 .2 7 .6 -1 15 56 0 . 8 2 . 6
1 15 44 3 . 3 3 .4 3 6 54 3 .1 1 . 7 0 15 5 5 . 1 4 . 8
1 54 1 .7 2 .3 4 6 54 2 . 0 1 .6 1 15 5 6 . 5 5 .8
- 3 1 5 5 . 0 4 . 6 - 4 7 54 1 . 9 2 . 5 - 4 0 66 1 .8 2 . 9
- 2 I 5 4 . 2 3 .3 - 3 7 54 3 .5 3 .5 - 3 0 6 1 0 .3 1 0 .6
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Table 7 (cont.)
H K L f (0 ) FtCI H K L f 101 F(CI H K L FfOl F(C1
- 2 0 6 6 . 9 6 . 8 - 3 6 6 3 6 .4 3 7 . 4 1 1« 66 2 .7 0 . 6
- 1 0 6 3 8 .4 3 5 .1 - 2 6 6 6 . 0 6 . 0 0 15 66 2 . 9 2 .6
0 0 6 2 1 . 8 2 3 * 2 - 1 6 6 4 . 2 3 . 7 - 4 1 76 0 . 8 1 .5
1 0 6 3 .0 3 .1 0 6 6 6 . 9 7 . 2 - 3 1 7 5 .2 5 . 0
2 0 6 6 . 2 6 . 0 1 6 6 3 5 .5 3 5 . 1 - 2 1 7 9 . 9 1 0 .1
3 0 6 3 6 .0 3 2 .6 2 6 66 2 .0 1 . 3 - 1 1 7 1 4 * 9 1 6 .7
4 0 64 2 . 0 0 . 9 3 6 66 2 . 6 3 . 2 0 1 7 6 . 8 7 . 2
1 6* 3 .7 3 .8 - 3 7 6 4 . 7 3 . 7 1 1 7 U.B 1 2 .5
- 3 1 64 3*1 3 .9 - 2 7 6 8 . 7 8 . 6 2 1 76 1*7 2 . 6
- 2 1 6 1 7 .7 1 5 .6 - 1 7 6 3 .6 3 . 3 3 1 7 4 . 9 5 . 6
- 1 1 6 2 5 .8 2 5 . 3 0 7 6 2 .8 2 . 9 4 1 76 2 . 6 1*2
0 1 6 1 4 .7 1 4 .6 1 7 66 1 .7 1 . 0 - 4 2 76 3 . 2 0 . 5
1 1 6 4 . 4 4 .1 2 7 6* 1 .5 0 . 4 - 3 2 7 7 . 5 6 . 6
2 1 6 1 0 .5 1 1 .0 3 7 66 1 .6 G. 6 - 2 2 7 1 8 .9 1 8 .6
3 1 6 6 . 3 6 . 6 - 3 8 6 7 .3 6. 1 - 1 2 76 2 . 2 1 .6
h 1 6 4 3*2 5 .6 - 2 8 66 2 . 8 2 . 5 0 2 76 1 .3 0 .7
2 6 4 2 .5 1 .2 >1 8 6 6 .3 6 . 5 1 2 7 1 5 .3 1 5 .2
- 3 2 6 4 0 .8 0 . 9 0 8 6 6 .4 5 . 9 2 2 76 0 . 7 2 . 2
- 2 2 64 2 . i 2 . 0 1 8 6 1 7 .3 1 6 . 4 3 2 76 2 . 9 3 . 0
- 1 2 6 2 8 .4 2 8 . 5 2 a 6 4 . 5 4 . 9 4 2 76 2 . 7 6 . 7
0 2 6 1 2 .2 1 1 .9 3 8 66 1 .7 1 . 4 - 4 3 76 2 . 7 1 .9
1 2 6 1 3 .5 1 3 .9 - i 9 66 1 .6 C. 9 - 3 3 7 3 . 6 3 . 8
2 2 6 4 1 .5 3 .2 - 2 9 6 1 0 .4 1 C.a - 2 3 76 2 *5 2 .6
3 2 6 1 5 .6 1 4 .7 -1 9 66 3 .2 1 .7 -1 3 7 8 . 4 8 .6
2 64 0 .8 0 .2 0 9 6 1 5 .4 1 5 . 9 0 3 7 1 2 .2 1 2 .6
3 64 0 .6 1 .9 1 9 6 5 .4 6 . 0 1 3 7 1 2 .9 1 2 .8
- 3 3 6 4 .1 3 .4 2 9 66 2 .1 C. 4 2 3 7 6 . 3 5 .9
- 2 3 6 6 . 0 5 .9 3 9 6 4 . 9 5 . 9 3 3 7 7 . 5 6 . 8
- 1 3 6 4 . 8 3./ - 3 10 66 0 .8 0 . 8 4 3 76 0 . 8 0 . 9
0 3 6 4 2 . 7 4 3 . 0 - 2 10 66 1 .6 2 . 1 - 4 4 76 2 . 9 1 .6
1 3 t 1 5 .3 1 5 .2 - 1 to 6 4 . 6 5 . 7 - 3 4 7 9 . 9 8 . 5
2 3 6 3 .5 3 .4 0 10 66 l.I 0 . 9 - 2 4 76 1 .5 0 . 8
3 3 6 5 .5 5 .4 1 10 6 4 . 5 4 . 2 - 1 4 7 7 .6 7 .3
3 6 4 2 . 1 0 .1 2 10 6 6 . 0 4 . 9 0 4 7 7 .0 7 .2
4 64 0 . 6 1 .7 3 10 6 7 .9 9 . 6 1 4 7 4 . 9 6 . 9
- 3 4 6 2 4 . 7 2 2 . 9 - 3 11 66 2 . 0 0 . 6 2 4 76 2 . 9 2 . 8
- 2 4 6 4 2 . 0 1 .4 - 2 11 6 4 . 8 5 . 6 3 4 76 1 .5 0 . 6
- 1 4 6 5 .2 5 .7 - 1 11 6 3 .7 2 . 2 4 4 76 2 .5 0 . 8
0 4 6 7 .5 8 .2 0 11 6 7 .3 7 .3 - 4 5 76 2 . 2 1 .1
1 4 6 2 6 . 0 2 6 .4 1 11 6 3*8 3 . 0 - 3 5 7 4 *1 3 . 7
2 4 6 3 .6 4 . 6 2 11 6 5 .4 5 . 0 - 2 5 7 1 6 .8 17*2
3 4 64 2 .4 2 . 5 - 2 12 66 2 . 2 2 . 9 - 1 5 7 9 . 3 9 . 6« 4 6 4 0 . 8 0 . 6 - 1 12 6 1 3 .9 1 5 . 4 0 5 7 1 3 .0 1 3 .1
5 6 5 .8 7 .2 0 12 6 6 . 7 6 . 6 1 5 7 1 6 .9 1 6 .6
- 3 S 6 7 .0 5 . 8 i 12 6* 2 .1 2 . 0 2 5 7 5 . 4 5 . 9
- 2 5 6 4 . 0 2 . 4 2 12 66 0 .8 3 . 4 3 5 76 0 * 6 1 .1
- 1 5 6 8 .4 8 . 8 - 2 13 66 2 .6 2. 7 - 3 Ö 7 7 .4 7 .3
0 5 6 1 8 .5 1 7 .4 - 1 13 66 2 .3 3 . 5 - 2 6 7 1 0 .0 1 0 .9
1 5 6 4 1 .9 0 . 6 0 13 66 2 . 4 1 . 9 -1 6 76 1 . 5 2 . 2
2 5 6 9 .1 9 . 5 1 13 6 4 .2 3 .^ 0 6 76 1 .6 1 .0
3 5 64 2 . 0 1 .1 2 13 66 3 .5 3 . 6 1 6 7 5 *3 6 . 5
4 5 6 4 2 . 0 3 .C - 1 14 66 0 .8 2 . 6 2 6 76 1 .8 0 .1
- 4 6 6 4 3 .7 3 . 5 0 14 66 3 .1 0 . 1 3 6 76 0 . 8 0 . 2
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Table 7 (cont.)
H K 1 F(CI FIO H K L FCOl FIO H K L FIOI FCCI
1 9 1 3* 0 * 8 0 . 5 2 4 144 2 . 2 2 . 2 0 3 15 4 . 7 4 *6
- 1 to 13 5*1 3 .9 - 2 5 14 7 .0 5 . 9 1 3 154 1 *7 1 .0
0 10 1 3« 2 . 2 1*6 - 1 5 144 1 .7 2 . 2 - 1 4 15 7 .2 6 . 6
- 2 0 14 8 * 8 8 . 0 0 5 144 3 .2 2 . 9 0 4 154 1 .9 1 .5
- 1 0 14 7*6 6 .7 1 5 14 18* 8 1 8 .6 1 4 15 7 .0 7 .4
0 0 14 3 *8 4*2 2 5 144 3 .1 2 . 2 - 1 5 15 4 . 0 3 .0
t 0 144 3*4 2*8 - 2 6 144 3 .2 2 .1 0 5 154 0 . 8 0 .4
2 0 14 4 *S 4 .2 - 1 ò 144 1 .7 0 . 1 1 5 154 3 .1 3*5-2 1 144 1 . 9 0 . 0 0 6 14 7 . 5 7 . 3 -1 6 154 1 .8 1 .4
- 1 1 14 1 7 .4 1 7 .9 1 6 144 0 . 9 3 .2 0 6 154 0 . 8 1 .5
0 1 144 2. 1 2 .1 - 1 7 14 5 .1 4 . 8 1 6 154 0 . 8 0 .51 t 144 2 . 2 2 . 6 0 7 144 0 . 8 2 . 0 0 7 154 1 . 3 1 .5
2 1 144 0 . 9 0 * 2 1 7 14 1 3 .8 1 3 .3 -1 0 16 3 . 9 3 .5
- 2 2 144 1 .8 2 *6 -1 8 14 4 . 8 4 . 4 0 0 16 9 . 6 9 .3
- 1 2 144 0 . 8 0*9 0 8 144 1 .5 2 . 6 1 0 164 0 . 8 0 .8
0 2 144 2 .1 1*4 1 8 144 1.8 0 . 9 -1 1 164 2 . 4 2 .91 2 14 5 .1 4 .2 0 9 144 1 .5 C. 5 0 1 16 7 . 3 6. 82 2 144 2 .1 1 .4 - 2 1 154 2 . 7 2 . 7 1 1 164 2 . 8 1 .3-2 3 14 4 . 2 3 .6 -1 1 154 3 .4 2 . 3 - 1 2 164 2 . 2 3 .4
- 1 3 14 1 0 . 7 lü.ô 0 1 154 0 . 8 1 .8 0 2 16 1 1 .0 9 . 9
0 3 144 2 . 0 2 .6 1 1 154 2 . 0 0 . 4 1 2 164 1 .7 0 .9
1 3 14 7 .7 8 .3 - 2 2 15 4 . 3 3 .2 - 1 3 164 0 . 8 0 .7
2 3 144 0*9 1 .8 - 1 2 15 5 .4 6 . 0 0 3 164 1 .3 0 .4
- 2 « 144 2 . 5 2 .9 0 2 154 2 .7 1 .2 1 3 16 4 . 0 3 .3
- 1 4 14 4 . 7 3 .9 1 2 15 4 . 7 4 . 7 - 1 4 164 0 . 8 0 .4
0 4 14 5 . 9 5 .6 - 2 3 154 3 .0 3 .2 0 4 16 5 .1 4 . 7
1 4 144 2 . 7 3 .3 -1 3 15 4 . 4 4 . 6 5 164 2 . 6 0 .3
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